
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Genes Nutr</journal-id><journal-id journal-id-type="iso-abbrev">Genes Nutr</journal-id><journal-title-group><journal-title>Genes &#x00026; Nutrition</journal-title></journal-title-group><issn pub-type="ppub">1555-8932</issn><issn pub-type="epub">1865-3499</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29662554</article-id><article-id pub-id-type="pmc">5892041</article-id><article-id pub-id-type="publisher-id">598</article-id><article-id pub-id-type="doi">10.1186/s12263-018-0598-2</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Effect of &#x003b2;-hydroxy-&#x003b2;-methylbutyrate on miRNA expression in differentiating equine satellite cells exposed to hydrogen peroxide</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chodkowska</surname><given-names>Karolina A.</given-names></name><address><email>landadelka82@o2.pl</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Ciecierska</surname><given-names>Anna</given-names></name><address><email>anna_ciecierska@sggw.pl</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Majchrzak</surname><given-names>Kinga</given-names></name><address><email>kinga_majchrzak@sggw.pl</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Ostaszewski</surname><given-names>Piotr</given-names></name><address><email>piotr_ostaszewski@sggw.pl</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9175-7110</contrib-id><name><surname>Sadkowski</surname><given-names>Tomasz</given-names></name><address><phone>+48 22 8472452</phone><email>tomasz_sadkowski@sggw.pl</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1955 7966</institution-id><institution-id institution-id-type="GRID">grid.13276.31</institution-id><institution>Department of Physiological Sciences, Faculty of Veterinary Medicine, </institution><institution>Warsaw University of Life Sciences &#x02013; SGGW, </institution></institution-wrap>Nowoursynowska 159, 02-776 Warsaw, Poland </aff></contrib-group><pub-date pub-type="epub"><day>10</day><month>4</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>10</day><month>4</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>13</volume><elocation-id>10</elocation-id><history><date date-type="received"><day>19</day><month>6</month><year>2017</year></date><date date-type="accepted"><day>14</day><month>3</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2018</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Skeletal muscle injury activates satellite cells to initiate processes of proliferation, differentiation, and hypertrophy in order to regenerate muscle fibers. The number of microRNAs and their target genes are engaged in satellite cell activation. &#x003b2;-Hydroxy-&#x003b2;-methylbutyrate (HMB) is known to prevent exercise-induced muscle damage. The purpose of this study was to evaluate the effect of HMB on miRNA and relevant target gene expression in differentiating equine satellite cells exposed to H<sub>2</sub>O<sub>2</sub>. We hypothesized that HMB may regulate satellite cell activity, proliferation, and differentiation, hence attenuate the pathological processes induced during an in vitro model of H<sub>2</sub>O<sub>2</sub>-related injury by changing the expression of miRNAs.</p></sec><sec><title>Methods</title><p id="Par2">Equine satellite cells (ESC) were isolated from the samples of skeletal muscle collected from young horses. ESC were treated with HMB (24&#x000a0;h) and then exposed to H<sub>2</sub>O<sub>2</sub> (1&#x000a0;h). For the microRNA and gene expression assessment microarrays, technique was used. Identified miRNAs and genes were validated using real-time qPCR. Cell viability, oxidative stress, and cell damage were measured using colorimetric method and flow cytometry.</p></sec><sec><title>Results</title><p id="Par3">Analysis of miRNA and gene profile in differentiating ESC pre-incubated with HMB and then exposed to H<sub>2</sub>O<sub>2</sub> revealed difference in the expression of 27 miRNAs and 4740 genes, of which 344 were potential target genes for identified miRNAs. Special attention was focused on differentially expressed miRNAs and their target genes involved in processes related to skeletal muscle injury. Western blot analysis showed protein protection in HMB-pre-treated group compared to control. The viability test confirmed that HMB enhanced cell survival after the hydrogen peroxide exposition.</p></sec><sec><title>Conclusions</title><p id="Par4">Our results suggest that ESC pre-incubated with HMB and exposed to H<sub>2</sub>O<sub>2</sub> could affect expression on miRNA levels responsible for skeletal muscle development, cell proliferation and differentiation, and activation of tissue repair after injury. Enrichment analyses for targeted genes revealed that a large group of genes was associated with the regulation of signaling pathways crucial for muscle tissue development, protein metabolism, muscle injury, and regeneration, as well as with oxidative stress response.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (10.1186/s12263-018-0598-2) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>miRNA</kwd><kwd>HMB</kwd><kwd>Equine satellite cells</kwd><kwd>Muscle injury</kwd><kwd>Skeletal muscle</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004281</institution-id><institution>Narodowe Centrum Nauki</institution></institution-wrap></funding-source><award-id>2011/03/B/NZ5/05697</award-id><principal-award-recipient><name><surname>Sadkowski</surname><given-names>Tomasz</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par19">&#x003b2;-Hydroxy-&#x003b2;-methylbutyrate (HMB) is a metabolite of the essential amino acid leucine and is naturally synthesized in animals, plants, and humans [<xref ref-type="bibr" rid="CR1">1</xref>]. Dietary supplementation of HMB is used to enhance gains in strength and lean body mass associated with resistance training and for increasing lean mass in cancer-related cachexia [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Unlike anabolic hormones which only increase muscle protein synthesis to accelerate muscular hypertrophy, HMB increases dynamic strength [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>] and lean body mass [<xref ref-type="bibr" rid="CR6">6</xref>] acting as an anti-catabolic agent, reducing protein breakdown [<xref ref-type="bibr" rid="CR5">5</xref>] and cellular damage which may accompany intense exercise [<xref ref-type="bibr" rid="CR7">7</xref>]. Moreover, previous studies have demonstrated that HMB supplementation decreased plasma post-exercise creatine kinase and lactic acid in thoroughbreds [<xref ref-type="bibr" rid="CR8">8</xref>].</p><p id="Par20">Reactive oxygen species (ROS), such a hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), exert a critical regulatory role on skeletal muscle function [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. In resting muscle cells, free radicals and ROS are rapidly and efficiently neutralized by antioxidants. Exercise creates an imbalance between ROS and activates natural antioxidant mechanisms. Moreover, ROS produced during exercise by inflammatory cells may also be involved in delayed onset of muscle damage observed during inflammation [<xref ref-type="bibr" rid="CR11">11</xref>]. The inflammatory response coincides with muscle repair, regeneration, and growth, involving activation and proliferation of satellite cells followed by their terminal differentiation. In response to the damage, quiescent satellite cells are activated and undergo several cycles of cell division prior to their withdrawal from the cell cycle through terminal differentiation and finally fusion with the damaged skeletal muscle fibers [<xref ref-type="bibr" rid="CR12">12</xref>]. During training-related tissue microdamage, activation of satellite cells is considered to play a crucial role in injured muscle fibers by incorporating new myonuclei and thus increasing muscle size and strength (by hypertrophy) [<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par21">MicroRNAs (miRNAs) are small non-coding interfering RNA molecules (18&#x02013;25 nucleotides) able to post-transcriptionally regulate gene expression through sequence-specific base pairing to messenger ribonucleic acid (mRNA). These molecules have been shown to be important key players in a variety of physiological and pathological processes (proliferation, differentiation, apoptosis, hypertrophy, timing development, inflammation, cancer, etc.). A group of miRNAs, highly enriched in skeletal and/or cardiac muscles (myomiRs), has recently been identified and includes miR-1, miR-133a, miR-133b, miR-206, miR-208, miR-208b, miR-486, and miR-499 [<xref ref-type="bibr" rid="CR14">14</xref>] which regulate skeletal muscle development.</p><p id="Par22">Szcze&#x0015b;niak et al. [<xref ref-type="bibr" rid="CR15">15</xref>] were the first who demonstrated the effect of HMB in ESC. Our study was performed to evaluate miRNA profile and relevant target genes in differentiating equine satellite cells incubated with HMB and also exposed to H<sub>2</sub>O<sub>2</sub> an in vitro factor initiating cellular response similar to that observed in vivo during a short intensive physical exercise and post-exercise injury.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Muscle samples and cell culture</title><p id="Par23">Samples of skeletal muscles (<italic>m. semitendinosus</italic>) were collected from 6&#x000a0;months old healthy stallions in a slaughter house. Muscle samples (0.5&#x02009;&#x000d7;&#x02009;0.5&#x02009;&#x000d7;&#x02009;0.5&#x000a0;cm) were taken immediately, washed in phosphate<italic>-</italic>buffered saline (PBS) with gradually decreasing antibiotic concentration [40.000 and 20.000&#x000a0;IU <italic>Penicillium crystalicum</italic> (PC; Polfa, Poland) per 100&#x000a0;ml PBS], cleaned from connective and fat tissue, cut and immediately suspended in sterile fetal bovine serum (FBS; Life Technologies, USA) with 10% addition of dimethylsulfoxide (DMSO), gradually frozen to &#x02212;&#x02009;80&#x000a0;&#x000b0;C, and finally stored in liquid nitrogen until use.</p></sec><sec id="Sec4"><title>Satellite cell isolation, proliferation, and differentiation</title><p id="Par24">Equine satellite cells (ESC) were isolated according to the following protocol. Protease from <italic>Streptomyces griseus</italic> (Pronase&#x000ae;, Sigma-Aldrich, USA) was reconstituted in low-glucose Dulbecco's modified Eagle&#x02019;s medium (DMEM), GlutaMAX&#x02122;, Pyruvate (Life Technologies, USA), and stirred for 1&#x000a0;h, pH 7.3. The incubation buffer (IB) consisted per sample of Pronase 0.5&#x000a0;mg/ml, 18&#x000a0;ml of DMEM, FBS 2&#x000a0;ml (Life Technologies, USA), and PC (20.000&#x000a0;IU). IB was filtered through a cellulose acetate membrane syringe filter (Sigma-Aldrich, USA). The fragmented muscle tissue was thawed, washed in PBS with PC (20.000&#x000a0;IU), and suspended in IB for 1.5&#x000a0;h at 37&#x000a0;&#x000b0;C, shaken every 15&#x000a0;min. Then, samples were sieved through cell strainer (70&#x000a0;&#x003bc;m, nylon, Falcon, USA)<italic>.</italic> The filtrate was centrifuged for 20&#x000a0;min (350&#x000a0;g), which was repeated three times. After each centrifugation, supernatant was discarded, cell pellet was re-suspended in growth medium (GM; 10%FBS/10% horse serum (HS) in DMEM (Life Technologies, USA) and antibiotics (AB; 0.5% amphotericin B (Fungizone, Life Technologies, USA), 1% penicillin-streptomycin (Life Technologies, USA)). After the last centrifugation, cell suspension was transferred to polystyrene Petri dishes (Becton Dickinson, USA) for 1.5&#x000a0;h to allow adhesion of fibroblast. After that, supernatant with satellite cells was transferred into culture dishes (Primaria Cell Culture Flask, Becton Dickinson, USA) and cultured in GM. The growth medium was changed every 2&#x000a0;days. On the tenth day of proliferation, cells were trypsinized, counted by Scepter Cell Counter (Merck Millipore, Germany), transferred (30,000 cells from each isolation) to Collagen I Cellware six-well plate (Greiner Bio-One, USA), and cultured in GM. After reaching 80% confluency, the proliferation media was replaced by the differentiation media (DM; 2%HS in DMEM with AB).</p><p id="Par25">Primary satellite cell cultures from semitendinosus muscle of all horses were isolated, and the culture with the best scores of cell viability (MTT assay) [<xref ref-type="bibr" rid="CR16">16</xref>] and fusion index was selected for further analysis (data not shown). Different stages of equine satellite cell culture are presented in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>.<fig id="Fig1"><label>Fig. 1</label><caption><p>Equine satellite cell culture. <bold>a</bold> Proliferating ESC, day 4. <bold>b</bold> Proliferating ESC, day 8. <bold>c</bold> Myotubes in differentiating ESC, day 2</p></caption><graphic xlink:href="12263_2018_598_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec5"><title>Experimental design</title><p id="Par26">After the second day of differentiation, 50&#x000a0;&#x003bc;M HMB (Metabolic Technologies Inc., USA) was added to the culture media, and then, cells were incubated for an additional 24&#x000a0;h. Ca-HMB was purchased from MTI (USA). The free HMB acid was extracted by acidification and organic extraction [<xref ref-type="bibr" rid="CR8">8</xref>]. HMB dose was chosen based upon previous studies [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR17">17</xref>] and MTT assay results which confirmed literature data (data not shown). During the last hour of incubation, 3&#x000a0;mM hydrogen peroxide (solution 30% (<italic>w</italic>/<italic>w</italic>) in H<sub>2</sub>O (Sigma-Aldrich, USA) was added to induce cell damage. Due to the lack of literature data on the doses of H<sub>2</sub>O<sub>2</sub> used in the equine satellite cell culture, the MTT assay was performed using doses ranging for 0.125 to 50&#x000a0;mM. Compared to the previously described doses of H<sub>2</sub>O<sub>2</sub> used in other cell culture models, those used for ESCs were relatively large. For this reason, we decided to use H<sub>2</sub>O<sub>2</sub> dose 3&#x000a0;mM with DL-25 (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). The experimental design is presented in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>.<fig id="Fig2"><label>Fig. 2</label><caption><p>H<sub>2</sub>O<sub>2</sub> dose-dependent effect on ESC cell viability assessed by MTT assay</p></caption><graphic xlink:href="12263_2018_598_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>Experimental design. <bold>a</bold> Control group. <bold>b</bold> HMB-treated group</p></caption><graphic xlink:href="12263_2018_598_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec6"><title>RNA isolation</title><p id="Par27">After the H<sub>2</sub>O<sub>2</sub> treatment, the differentiating ESCs were scraped and total RNA was isolated using a miRNeasy Mini Kit (Qiagen, USA) according to the manufacturer&#x02019;s protocol. The quantity of RNA was measured spectrophotometrically using NanoDrop 2000 (Thermo Scientific, USA). The quality of the total RNA was verified by Bioanalyzer 2100 (Agilent, USA), and only samples with RIN&#x02009;&#x02265;&#x02009;9.2 were used for further analysis.</p></sec><sec id="Sec7"><title>Microarray analysis</title><p id="Par28">For the microRNA profiling, the Custom Equine miRNA 8x15K Microarray slides were designed using eArray platform (<ext-link ext-link-type="uri" xlink:href="https://earray.chem.agilent.com/earray">https://earray.chem.agilent.com/earray</ext-link>, GEO database: GPL20990) and provided by Agilent Technologies (USA).</p><p id="Par29">MiRNA was isolated from eight equine satellite cell cultures for both HMB pre-treated (<italic>n</italic>&#x02009;=&#x02009;8) and control group (<italic>n</italic>&#x000a0;=&#x02009;8). As recommended by Agilent Technologies (USA), 100&#x000a0;ng of total RNA of each sample was taken and labeled using miRNA Complete Labeling and Hyb Kit (version 2.3, December 2010). For hybridization, Microarray Hybridization Chamber (Agilent, USA) and Hyb-Buffer (Agilent, USA) were used according to the manufacturer&#x02019;s protocol. In the next step, slides were washed out using Gene Expression Wash Pack (Agilent, USA) and scanned in Microarray Scanner (model G2565CA) with SureScan High-Resolution Technology (Agilent, USA).</p><p id="Par30">Microarray data were extracted, the background was subtracted, and normalization was performed using the standard procedures included in the Agilent Feature Extraction (FE) Software version 10.7.3.1.</p><p id="Par31">Analysis of gene expression (GE) profile was performed using Horse Gene Expression Microarray, 4x44K (Agilent Technologies, USA) based on the same protocol as described by Szcze&#x0015b;niak et al. (2016), [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Briefly, two-color microarray, with 825&#x000a0;ng of cRNA from HMB-exposed cells (labeled by Cy5, <italic>n</italic>&#x02009;=&#x02009;4) and 825&#x000a0;ng of cRNA from control cells (labeled by Cy3, <italic>n</italic>&#x02009;=&#x02009;4), and RNA Spike-In Kit (Agilent Technologies, USA) as an internal control were used. The background was subtracted and Linear and Lowess normalization was performed using the standard procedures included in the Agilent Feature Extraction (FE) Software version 10.7.3.1. The data were statistically analyzed using Gene Spring 13.0 software (Agilent, USA). The statistical significance of the differences was evaluated using Student&#x02019;s <italic>t</italic> test (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) and Benjamini and Hochberg multiple testing correction. False Discovery Rate (FDR) &#x02264;&#x02009;0.05 and fold change (FC) &#x02265;&#x02009;1.3 were considered as statistically significant. Microarray data were deposited at the Gene Expression Omnibus data repository under the number GSE73779 for miRNA and GSE93025 for cDNA.</p></sec><sec id="Sec8"><title>Real-time qPCR</title><p id="Par32">The criteria for miRNA and differentially expressed gene (DEG) selection for real-time qPCR validation and further analysis were of biological relevance (miRNAs linked to muscular development, hypertrophy, muscle injuries, oxidative stress, and tissue regeneration) and were assessed based on Pathway Studio Mammalian (Elsevier, USA) and available literature.</p><p id="Par33">For miRNA, real-time qPCR validation miRCURY LNA&#x02122; Universal RT microRNA PCR kit (Exiqon, USA) was used. A two-step protocol was applied: (1) polymerase activation at 95&#x000a0;&#x000b0;C for 10&#x000a0;min and (2) 40 amplification cycles at 95&#x000a0;&#x000b0;C for 10s and 60&#x000a0;&#x000b0;C for 1&#x000a0;min, according to the manufacturer protocol.</p><p id="Par34">Primers were chosen based on the miRNA sequences assigned to microarray probes and were provided by Exiqon (Denmark) (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Calculation of the relative miRNA expression using the &#x00394;&#x00394;Ct method was applied using GenEX 6 software provided by MultiD (Sweden). Obtained data were statistically analyzed using two-tailed Student&#x02019;s <italic>t</italic> test. Values of <italic>p</italic>&#x02009;&#x02264;&#x02009;0.05 were considered statistically significant.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Primers for real-time qPCR: primers for miRNA</p></caption><table frame="hsides" rules="groups"><thead><tr><th>No.</th><th>Primer&#x02019;s name</th><th>Target sequence</th><th>Amplification time and temperature</th></tr></thead><tbody><tr><td>1</td><td>miR-146a-5p</td><td>UGAGAACUGAAUUCCAUGGGUU</td><td>10&#x000a0;s/95&#x000a0;&#x000b0;C and 60&#x000a0;s/60&#x000a0;&#x000b0;C</td></tr><tr><td>2</td><td>miR-146b-5p</td><td>UGAGAACUGAAUUCCAUAGGCU</td><td>10&#x000a0;s/95&#x000a0;&#x000b0;C and 60&#x000a0;s/60&#x000a0;&#x000b0;C</td></tr><tr><td>3</td><td>miR-204b</td><td>UUCCCUUUGUCAUCCUAUGCCU</td><td>10&#x000a0;s/95&#x000a0;&#x000b0;C and 60&#x000a0;s/60&#x000a0;&#x000b0;C</td></tr><tr><td>4</td><td>miR-208b</td><td>AUAAGACGAACAAAAGGUUUGU</td><td>10&#x000a0;s/95&#x000a0;&#x000b0;C and 60&#x000a0;s/60&#x000a0;&#x000b0;C</td></tr><tr><td>5</td><td>miR-222</td><td>AGCUACAUCUGGCUACUGGGU</td><td>10&#x000a0;s/95&#x000a0;&#x000b0;C and 60&#x000a0;s/60&#x000a0;&#x000b0;C</td></tr><tr><td>6</td><td>miR-675</td><td>UGGUGCGGAGAGGGCCCACAGUG</td><td>10&#x000a0;s/95&#x000a0;&#x000b0;C and 60&#x000a0;s/60&#x000a0;&#x000b0;C</td></tr></tbody></table></table-wrap></p><p id="Par35">Based on previous studies in different species and the manufacturer recommendation (Exiqon, Denmark), a U6 snRNA reference was used. To verify GE microarray results, the real-time qPCR method was applied. All the steps of real-time qPCR procedure were made based on the protocols previously described by Szcze&#x0015b;niak et al. (2016), [<xref ref-type="bibr" rid="CR15">15</xref>]. The sequences of primers are listed in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. <italic>Gapdh</italic> was used as a reference gene.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Primers for real-time qPCR: primers for mRNA</p></caption><table frame="hsides" rules="groups"><thead><tr><th>No.</th><th>Primer&#x02019;s name</th><th>Forward sequence</th><th>Reverse sequence</th><th>Annealing time and temperature</th></tr></thead><tbody><tr><td>1</td><td>
<italic>otud4</italic>
</td><td>CCACCTCCTGCAGAACAAAAG</td><td>GGGTCTTGGTAAAGGCTCATT</td><td>15&#x000a0;s/60&#x000a0;&#x000b0;C</td></tr><tr><td>2</td><td><italic>cx43</italic> (<italic>gja1</italic>)</td><td>TGCTGCGAACCTACATCATC</td><td>CGATGACGTTCAAGGCAAGA</td><td>15&#x000a0;s/60&#x000a0;&#x000b0;C</td></tr><tr><td>3</td><td>
<italic>sod2</italic>
</td><td>GTCACCGAGGAGAAGTACCA</td><td>CTGGTTAGGACAGGCAACAA</td><td>15&#x000a0;s/60&#x000a0;&#x000b0;C</td></tr><tr><td>4</td><td>
<italic>sod1</italic>
</td><td>GATTCCACGTCCACGAGTTT</td><td>CCCGAGAGTGAGATCACAGA</td><td>15&#x000a0;s/60&#x000a0;&#x000b0;C</td></tr><tr><td>5</td><td>
<italic>tgfb2</italic>
</td><td>AGTACTACGCCAAGGAGGTT</td><td>TAGGCGGGATGGCATTTTCC</td><td>15&#x000a0;s/60&#x000a0;&#x000b0;C</td></tr><tr><td>6</td><td>
<italic>myf5</italic>
</td><td>GGAGACGCCTGAAGAAAGTC</td><td>CCGGCAGGCTGTAGTAATTC</td><td>15&#x000a0;s/60&#x000a0;&#x000b0;C</td></tr><tr><td>7</td><td>
<italic>bdnf</italic>
</td><td>CCCCATGAAAGAAGCAAACG</td><td>TACAAGTCCGCGTCCTTACT</td><td>15&#x000a0;s/60&#x000a0;&#x000b0;C</td></tr><tr><td>8</td><td>
<italic>gapdh</italic>
</td><td>GTTTGTGATGGGCGTGAACC</td><td>GTCTTCTGGGTGGCAGTGAT</td><td>15&#x000a0;s/60&#x000a0;&#x000b0;C</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec9"><title>Target gene prediction and ontological analyses</title><p id="Par36">MicroRNA target gene prediction was performed using the TargetScan database. The analysis was performed for all identified HMB-affected miRNAs. For each predicted target of individual miRNA, the sum of the context + scores was automatically calculated. Predicted targets of each miRNA family were automatically sorted by total context + score. Analysis was performed for the context score percentile (50) and conserved/non-conserved miRNA families and target sites [<xref ref-type="bibr" rid="CR19">19</xref>]. For further analysis, common genes for those identified genes using GE microarray and predicted miRNA target genes were selected and considered as targets for HMB treatment-influenced miRNAs.</p><p id="Par37">Ontological analyses revealing molecular functions, biological processes, and pathways of miRNA targets were performed in DAVID 6.7 using Fisher&#x02019;s exact test with <italic>p</italic>&#x02009;&#x02264;&#x02009;0.05. Detailed analysis of the role of HMB-modulated miRNAs, genes identified using GE, and target genes in various metabolic and signal pathways was performed using Pathway Studio Web (Elsevier, USA). Relationships between all differentially expressed miRNAs were visualized with Pathway Studio&#x02019;s Build Pathway functionality which is based on the wave-propagation algorithm developed for the navigation through complex networks. Find Direct Links/All objects Directions Algorithm was used in this analysis.</p></sec><sec id="Sec10"><title>Western blot analysis</title><p id="Par38">The procedure of Western blot analysis was performed based on the previously described methodology by Zielniok et al. [<xref ref-type="bibr" rid="CR20">20</xref>]. Antibodies used in Western blot were against the following: SOD1 (ab62800), SOD2 (ab13534), TGF&#x003b2;2 (sc-90), &#x003b1;-tubulin (ab176560), BDNF (sc-546), MYF5 (sc-302), GAPDH (sc-20357), and &#x003b2;-actin (sc-47778).</p></sec><sec id="Sec11"><title>Cell viability, cell damage, and oxidative stress</title><p id="Par39">Hydrogen peroxide, used in the experiment as a damage factor, is known to affect various cellular processes. Several tests related to the cell viability, cell damage, and oxidative stress were performed to assess the impact of HMB on the cellular processes following incubation with H<sub>2</sub>O<sub>2</sub>. Experimental conditions (incubation time, doses of HMB and H<sub>2</sub>O<sub>2</sub>) were the same as previously in the part related to the microarray and real-time qPCR analysis.</p><p id="Par40">CellROX&#x000ae; Green Reagent Kit (Life Technologies) was used to measure oxidative stress and cell death in ESC&#x02019;s based on the manufacturer protocol. Cells were seeded on 24-well plates at 0.05&#x02009;&#x000d7;&#x02009;10<sup>6</sup>&#x000a0;cells/cm<sup>2</sup>. Cells were incubated for 60&#x000a0;min with CellROX reagent in a final concentration 250&#x000a0;&#x003bc;M. During the last 15&#x000a0;min of staining, SYTOX Red Dead Cell was added (at the final concentration 5&#x000a0;nM). The samples were analyzed immediately after staining using FACS Aria II (BD Biosciences) flow cytometer. A total of 50,000 events per sample (<italic>n</italic>&#x02009;=&#x02009;3) were collected. This staining was performed on live cells during the proliferative phase (90% confluency). Data were analyzed using FlowJo (TreeStar, USA) and GraphPad Prism software.</p><p id="Par41">The second test related to oxidative stress called Total Antioxidant Capacity (TAC) Assay Kit (Abcam, UK) was used according to the manufacturer protocol. This test can measure either the combination of both small molecule antioxidants and proteins or small molecules alone in the presence of our proprietary Protein Mask. Cells were seeded on 96-well plates at 2&#x02009;&#x000d7;&#x02009;10<sup>6</sup> cells (<italic>n</italic>&#x02009;=&#x02009;6). After a 90-min incubation, the plate was read on Tekan System reader at 570&#x000a0;nm wavelength. Data were analyzed using GraphPad Prism software.</p><p id="Par42">Lipid peroxidation is the degradation of lipids that may accompany the activity of several cell damage factors including hydrogen peroxide. It is also one of the popular markers for oxidative stress. Lipid peroxidation Assay Kit (Sigma-Aldrich) was used to measure lipid peroxidation. All the procedure was performed based on the provided manufacturer protocol. The concentration of MDA was measured for <italic>n</italic>&#x02009;=&#x02009;6. The staining was performed on live cells during differentiation phase.</p><p id="Par43">In order to increase the reliability of the obtained results related to cell survival, the MTT test was also performed (<italic>n</italic>&#x000a0;=&#x02009;6) based on the previously published protocol [<xref ref-type="bibr" rid="CR16">16</xref>]. Data for both tests were analyzed using GraphPad Prism software.</p><p id="Par44">Qualitative flow cytometry assay for mitochondrial depolarization was also performed according to the manufacturer protocol. The 5,5&#x02032;,6,6&#x02032;-tetrachloro-1,1&#x02032;,3,3&#x02032;-tetraethylbenzimidazolylcarbocyanine iodide (JC-1, Sigma-Aldrich) was used. It is a cationic, lipophilic dye that accumulates in mitochondria and exhibits green fluorescence (525&#x000a0;nm) in its monomeric state. The mostly implemented application of JC-1 is detection of mitochondrial depolarization occurring in the early stages of apoptosis. JC-1 was dissolved in DMSO and medium II for a final concentration of 0.6&#x000a0;&#x003bc;M. The cells were incubated at 37&#x000a0;&#x000b0;C, washed, trypsinized, and resuspended in 2%FBS/PBS medium. Fifty thousand events were collected for each sample using FACS Aria II (BD Biosciences) flow cytometer. Fluorescence compensation was done for 525&#x000a0;nm. This staining was performed on live cells during the proliferative phase (90% of confluency; <italic>n</italic>&#x02009;=&#x02009;3). Data were analyzed using FlowJo (TreeStar, USA) and GraphPad Prism software.</p></sec></sec><sec id="Sec12"><title>Results</title><p id="Par45">In the &#x0201c;Results&#x0201d; and &#x0201c;Discussion&#x0201d; sections, gene symbols are marked in italics and lowercase. The arrows indicate the direction of expression change: &#x02193; and &#x02191; for down- and upregulation, respectively.</p><sec id="Sec13"><title>Microarray analysis</title><p id="Par46">Analysis of the miRNA expression in differentiating equine satellite cells incubated with HMB (24&#x000a0;h) and exposed to H<sub>2</sub>O<sub>2</sub> (1&#x000a0;h) revealed differences in 27 miRNAs. Among them, eight demonstrated higher expression and 19 lower expression when compared to control (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>MiRNAs differentially expressed in HMB-incubated equine satellite cells exposed to H<sub>2</sub>O<sub>2</sub>, compared to control</p></caption><table frame="hsides" rules="groups"><thead><tr><th>No.</th><th>Name</th><th>Regulation</th><th>FC ([HMB] vs [CTRL])</th><th>Log FC ([HMB] vs [CTRL])</th><th>FDR</th><th>miRBase accession no.</th></tr></thead><tbody><tr><td>1</td><td>eca-miR-146a</td><td>Up</td><td>120.92</td><td>6.92</td><td>2.74E&#x02212;18</td><td>MIMAT0013065</td></tr><tr><td>2</td><td>eca-miR-146b-5p</td><td>Up</td><td>2.68</td><td>1.42</td><td>9.66E&#x02212;07</td><td>MIMAT0012891</td></tr><tr><td>3</td><td>eca-miR-204b</td><td>Up</td><td>1.74</td><td>0.79</td><td>3.26E&#x02212;03</td><td>MIMAT0013112</td></tr><tr><td>4</td><td>eca-miR-222</td><td>Up</td><td>1.60</td><td>0.68</td><td>7.79E&#x02212;04</td><td>MIMAT0013204</td></tr><tr><td>5</td><td>eca-miR-155</td><td>Up</td><td>1.49</td><td>0.57</td><td>2.30E&#x02212;03</td><td>MIMAT0013182</td></tr><tr><td>6</td><td>eca-miR-193a-3p</td><td>Up</td><td>1.39</td><td>0.47</td><td>9.29E&#x02212;06</td><td>MIMAT0013026</td></tr><tr><td>7</td><td>eca-miR-221</td><td>Up</td><td>1.38</td><td>0.46</td><td>2.11E&#x02212;03</td><td>MIMAT0013203</td></tr><tr><td>8</td><td>eca-miR-101</td><td>Up</td><td>1.34</td><td>0.42</td><td>2.10E&#x02212;05</td><td>MIMAT0012951</td></tr><tr><td>9</td><td>eca-miR-142-3p</td><td>Down</td><td>105.23</td><td>&#x02212;&#x02009;6.72</td><td>2.81E&#x02212;16</td><td>MIMAT0013023</td></tr><tr><td>10</td><td>eca-miR-675</td><td>Down</td><td>97.37</td><td>&#x02212;&#x02009;6.60</td><td>1.71E&#x02212;17</td><td>MIMAT0013053</td></tr><tr><td>11</td><td>eca-miR-486-5p</td><td>Down</td><td>2.21</td><td>&#x02212;&#x02009;1.14</td><td>2.95E&#x02212;10</td><td>MIMAT0013186</td></tr><tr><td>12</td><td>eca-miR-542-5p</td><td>Down</td><td>2.10</td><td>&#x02212;&#x02009;1.07</td><td>1.71E&#x02212;03</td><td>MIMAT0013237</td></tr><tr><td>13</td><td>eca-miR-149</td><td>Down</td><td>1.86</td><td>&#x02212;&#x02009;0.89</td><td>4.68E&#x02212;10</td><td>MIMAT0012973</td></tr><tr><td>14</td><td>eca-miR-206</td><td>Down</td><td>1.66</td><td>&#x02212;&#x02009;0.73</td><td>1.76E&#x02212;06</td><td>MIMAT0013098</td></tr><tr><td>15</td><td>eca-miR-208b</td><td>Down</td><td>1.66</td><td>&#x02212;&#x02009;0.74</td><td>1.50E&#x02212;08</td><td>MIMAT0012900</td></tr><tr><td>16</td><td>eca-miR-133a</td><td>Down</td><td>1.62</td><td>&#x02212;&#x02009;0.70</td><td>4.99E&#x02212;09</td><td>MIMAT0012997</td></tr><tr><td>17</td><td>eca-miR-133b</td><td>Down</td><td>1.59</td><td>&#x02212;&#x02009;0.67</td><td>8.26E&#x02212;09</td><td>MIMAT0013097</td></tr><tr><td>18</td><td>eca-miR-128</td><td>Down</td><td>1.58</td><td>&#x02212;&#x02009;0.66</td><td>1.19E&#x02212;04</td><td>MIMAT0013076</td></tr><tr><td>19</td><td>eca-miR-542-3p</td><td>Down</td><td>1.53</td><td>&#x02212;&#x02009;0.61</td><td>5.92E&#x02212;06</td><td>MIMAT0013238</td></tr><tr><td>20</td><td>eca-miR-1</td><td>Down</td><td>1.49</td><td>&#x02212;&#x02009;0.57</td><td>2.86E&#x02212;05</td><td>MIMAT0012994</td></tr><tr><td>21</td><td>eca-miR-324-5p</td><td>Down</td><td>1.49</td><td>&#x02212;&#x02009;0.58</td><td>3.75E&#x02212;07</td><td>MIMAT0013033</td></tr><tr><td>22</td><td>eca-miR-450c</td><td>Down</td><td>1.49</td><td>&#x02212;&#x02009;0.58</td><td>2.86E&#x02212;05</td><td>MIMAT0013222</td></tr><tr><td>23</td><td>eca-miR-450a</td><td>Down</td><td>1.44</td><td>&#x02212;&#x02009;0.53</td><td>1.19E&#x02212;05</td><td>MIMAT0013219</td></tr><tr><td>24</td><td>eca-miR-532-3p</td><td>Down</td><td>1.44</td><td>&#x02212;&#x02009;0.53</td><td>1.02E&#x02212;07</td><td>MIMAT0013236</td></tr><tr><td>25</td><td>eca-miR-331</td><td>Down</td><td>1.37</td><td>&#x02212;&#x02009;0.46</td><td>1.60E&#x02212;07</td><td>MIMAT0013188</td></tr><tr><td>26</td><td>eca-miR-374b</td><td>Down</td><td>1.34</td><td>&#x02212;&#x02009;0.42</td><td>2.81E&#x02212;02</td><td>MIMAT0013214</td></tr><tr><td>27</td><td>eca-miR-30c</td><td>Down</td><td>1.31</td><td>&#x02212;&#x02009;0.39</td><td>2.41E&#x02212;07</td><td>MIMAT0012915</td></tr></tbody></table><table-wrap-foot><p>FDR&#x02009;&#x02264;&#x02009;0.05, FC&#x02009;&#x02265;&#x02009;1.3, <italic>n</italic>&#x02009;=&#x02009;8</p></table-wrap-foot></table-wrap></p><p id="Par47">Analysis of gene expression profile for the same experimental conditions as those mentioned above revealed difference in the expression of 4740 transcripts. After removing all duplicate values and unknown sequences, 1923 unique genes were found (Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>: Table S1).</p></sec><sec id="Sec14"><title>Functional analysis of identified miRNAs and differentially expressed genes (DEG)</title><p id="Par48">Based upon the Pathway Studio Web Software (Elsevier, USA) and available literature, the results were divided into groups containing miRNAs related to the specific cellular processes, as follows: (1) cell proliferation and differentiation (miR-1, miR-133a/b, miR-206, miR-128, miR-146a/b, miR-204, miR-155, miR-193a, miR-221/222, miR-324, miR-331, miR-374b, miR-486, miR-675), (2) muscle regeneration and hypertrophy (miR-1, miR-133a/b, miR-142, miR-128, miR-146b, miR-208b, miR-675), (3) oxidative stress and inflammation (miR-146a/b), and (4) others (miR-149, miR-30c, miR-532-3p, miR-532-5p, miR-542) (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><p>Identified miRNAs and their involvement in some selected physiological and pathological processes. MiRNAs in blue clouds were RT-qPCR-validated</p></caption><graphic xlink:href="12263_2018_598_Fig4_HTML" id="MO4"/></fig></p><p id="Par49">Functional analysis showed that GE microarray identified genes were significantly associated with the following biological processes: cellular processes, muscle organ development, proteolysis involved in cellular protein catabolic process, muscle cell differentiation, positive regulation of biological processes, cell death, apoptosis, regulation of cell proliferation, and positive regulation of inflammatory process (Additional&#x000a0;file&#x000a0;<xref rid="MOESM2" ref-type="media">2</xref>: Table S2).</p><p id="Par50">Among identified genes (DEG), special attention has been focused on a few important groups which are known to be HMB affected: muscle organ development (e.g., <italic>six1</italic>, <italic>myf5</italic>, <italic>acta1</italic>, <italic>cav1</italic>, <italic>myh3</italic>, <italic>myh7</italic>, <italic>myl2</italic>, <italic>myl3</italic>, <italic>sgcd</italic>, <italic>tgfb2</italic>), response to wounding/injury (e.g., <italic>jak2</italic>, <italic>igf2</italic>, several members of <italic>cxcl</italic> and interleukin genes, <italic>sod1</italic>, <italic>sod2</italic>), inflammatory response/innate immune response/oxidative stress (<italic>tlr3</italic>, <italic>tlr4</italic>, <italic>tlr10</italic>, <italic>cd40</italic>, <italic>cd44</italic>, <italic>igf2</italic>, <italic>itgb6</italic>, <italic>il-5</italic>, <italic>il-6</italic>, <italic>il-15</italic>, <italic>il-23</italic>, <italic>sod1</italic>, <italic>sod2</italic>, and a large group of chemokine ligand: <italic>ccl</italic>-<italic>1</italic>, <italic>ccl</italic>-<italic>2</italic>, <italic>ccl</italic>-<italic>5</italic>, <italic>ccl</italic>-<italic>8</italic>).</p></sec><sec id="Sec15"><title>RT-qPCR validation</title><p id="Par51">From the microarray results, six miRNAs and six genes were selected as a single representative for the aforementioned processes for further RT-qPCR validation. The analysis confirmed statistically significant differences in the expression of six miRNAs (miR-204, miR-208b, miR-222, miR-675, miR-146a, and miR-146b) and six genes (<italic>sod1</italic>, <italic>sod2</italic>, <italic>tgfb2</italic>, <italic>myf5</italic>, <italic>bdnf</italic>, <italic>otud4</italic>) in HMB-treated ESC when compared to control condition (CTRL) (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). All RT-qPCR validated miRNAs and genes presented the same trend as microarray results.<fig id="Fig5"><label>Fig. 5</label><caption><p>Expression of selected miRNAs (<bold>a</bold>) and genes (<bold>b</bold>) validated by RT-qPCR. Presented values are means&#x02009;&#x000b1;&#x02009;SE (*<italic>p</italic>&#x02009;&#x02264;&#x02009;0.05; **<italic>p</italic>&#x02009;&#x02264;&#x02009;0.01; <italic>***p</italic>&#x02009;&#x02264;&#x02009;0.001). HMB&#x02014;cells treated with HMB and exposed to H<sub>2</sub>O<sub>2</sub>. CTRL&#x02014;cells without HMB treatment, exposed to H<sub>2</sub>O<sub>2</sub> (<italic>n</italic>&#x02009;=&#x02009;6)</p></caption><graphic xlink:href="12263_2018_598_Fig5_HTML" id="MO5"/></fig></p></sec><sec id="Sec16"><title>Prediction and ontological analysis of miRNA target genes (DET)</title><p id="Par52">TargetScan analysis was performed to predict potential target genes for all identified miRNAs. The analysis revealed unique 3310 targets for downregulated and 2117 unique targets for upregulated miRNAs. We compared all identified HMB-regulated DEG and aforementioned predicted miRNA target genes to find those which could be regulated by HMB-induced miRNAs in ESC cultures exposed to H<sub>2</sub>O<sub>2</sub>. Finally, 344 differentially expressed target genes (DET) were identified.</p><p id="Par53">Functional analysis showed that DET were associated significantly with several processes which plays an important role in the physiological (protein metabolism, muscle tissue development, cellular homeostasis, apoptosis) and pathological (inflammation, cancer) conditions in muscular tissue (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>).<table-wrap id="Tab4"><label>Table 4</label><caption><p>Selected biological processes in which identified differentially expressed target genes (DET) were involved</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Category</th><th>Term</th><th>Count</th><th>FDR</th></tr></thead><tbody><tr><td>GOTERM_BP_DIRECT</td><td>Skeletal muscle tissue development</td><td>5</td><td>5.4E0</td></tr><tr><td>GOTERM_BP_DIRECT</td><td>Regulation of inflammatory response</td><td>5</td><td>7.6E0</td></tr><tr><td>GOTERM_BP_DIRECT</td><td>Positive regulation of protein catabolic process</td><td>5</td><td>1.7E1</td></tr><tr><td>GOTERM_BP_DIRECT</td><td>Actin filament organization</td><td>5</td><td>2.5E1</td></tr><tr><td>GOTERM_BP_DIRECT</td><td>Positive regulation of Notch signaling pathway</td><td>4</td><td>3.6E1</td></tr><tr><td>GOTERM_BP_DIRECT</td><td>Protein ubiquitination involved in ubiquitin-dependent protein catabolic process</td><td>7</td><td>3.7E1</td></tr><tr><td>GOTERM_BP_DIRECT</td><td>Muscle cell cellular homeostasis</td><td>3</td><td>4.5E1</td></tr><tr><td>GOTERM_BP_DIRECT</td><td>Regulation of apoptotic process</td><td>7</td><td>5.0E1</td></tr></tbody></table></table-wrap></p><p id="Par54">Signaling pathway analysis showed that 27 identified miRNAs could affected target genes involved in several important signaling pathways related to the processes previously described as modified by HMB and also some other which HMB was suspected to affect. The most meaningful pathways are the following: MAPK, RIG-I, Toll-like receptor, hypertrophic cardiomyopathy, ubiquitin-mediated proteolysis, Ras, and response to oxidative stress.</p></sec><sec id="Sec17"><title>Western blot analysis</title><p id="Par55">Western blot analysis of the level of reference proteins and five proteins related to the muscle tissue, muscle damage, and oxidative stress was performed. However, the results are difficult to interpret. Protein degradation at different levels was observed in all samples treated only with hydrogen peroxide (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>). In groups pre-incubated with HMB and H<sub>2</sub>O<sub>2</sub>, protein degradation was smaller or not observed. It is related to the protein degradation which is strongly linked to hydrogen peroxide effect.<fig id="Fig6"><label>Fig. 6</label><caption><p>Degradation of protein in H<sub>2</sub>O<sub>2</sub>-treated cell cultures</p></caption><graphic xlink:href="12263_2018_598_Fig6_HTML" id="MO6"/></fig></p></sec><sec id="Sec18"><title>Cell viability, cell damage, and oxidative stress</title><p id="Par56">To measure cell viability, two tests were used&#x02014;MTT and SYTOX Red Dead Cell (as a component of CellROX Green Reagent kit). In both tests, increased cell viability and decreased amount of dead cells were observed in a group pre-treated with HMB and incubated with H<sub>2</sub>O<sub>2</sub> than in a control group (incubated only with H<sub>2</sub>O<sub>2</sub>). All the results from these two tests were statistically significant (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05). The results of SYTOX Red Dead Cell (A) and MTT test (B) are presented in Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>.<fig id="Fig7"><label>Fig. 7</label><caption><p>Effect of HMB on cell viability measured by SYTOX Red Cell Dead assay (<bold>a</bold>) and MTT assay (<bold>b</bold>). Each value is the mean&#x02009;&#x000b1;&#x02009;standard error of the results (<italic>n</italic>&#x02009;=&#x02009;3, SYTOX Red Cell Dead assay; <italic>n</italic>&#x02009;=&#x02009;6, MTT assay). Statistical analysis was performed using the one-way ANOVA (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) and unpaired <italic>t</italic> test (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) for SYTOX Red Cell Dead and MTT assay, respectively. H<sub>2</sub>O<sub>2</sub>&#x02014;cells without HMB treatment and exposed to H<sub>2</sub>O<sub>2</sub>. H<sub>2</sub>O<sub>2</sub> + HMB&#x02014;cells treated with HMB and exposed to H<sub>2</sub>O<sub>2</sub></p></caption><graphic xlink:href="12263_2018_598_Fig7_HTML" id="MO7"/></fig></p><p id="Par57">Oxidative stress was measured using CellROX&#x000ae; Green Reagent. There was no significant difference between groups (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8a</xref>). Similar results were obtained with the test for lipid peroxidation. There were no statistically significant differences between HMB pre-treated group and control. However, surprisingly, higher lipid peroxidation trend was observed in a HMB pre-treated group compared to control (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8b</xref>).<fig id="Fig8"><label>Fig. 8</label><caption><p>Effect of HMB on oxidative stress&#x02014;CellROX&#x000ae; Green assay (<bold>a</bold>) and Lipid peroxidation assay (<bold>b</bold>). Each value is the mean&#x02009;&#x000b1;&#x02009;standard error of the results (<italic>n</italic>&#x02009;=&#x02009;3, CellROX&#x000ae; Green assay; <italic>n</italic>&#x02009;=&#x02009;6, lipid peroxidation assay). Statistical analysis was performed using the one-way ANOVA (<italic>p</italic>&#x000a0;&#x0003c;&#x02009;0.05) and unpaired <italic>t</italic> test (<italic>p</italic>&#x000a0;&#x0003c;&#x02009;0.05) for CellROX&#x000ae; Green assay and lipid peroxidation assay, respectively. H2O2&#x02014;cells without HMB treatment and exposed to H<sub>2</sub>O<sub>2</sub>. H<sub>2</sub>O<sub>2</sub> + HMB&#x02014;cells treated with HMB and exposed to H<sub>2</sub>O<sub>2</sub></p></caption><graphic xlink:href="12263_2018_598_Fig8_HTML" id="MO8"/></fig></p><p id="Par58">Qualitative flow cytometry assay for mitochondrial depolarization (JC-1) showed significant differences between the Q2 population (monomers + aggregates in %) and Q4 population (JC-1) in control and HMB pre-treated group. There was no significant difference between Q1 population (% of aggregates) and Q3 population (% of monomers) (Fig.&#x000a0;<xref rid="Fig9" ref-type="fig">9a</xref>).<fig id="Fig9"><label>Fig. 9</label><caption><p>Qualitative flow cytometry assay for mitochondrial depolarization (<bold>a</bold>) and total antioxidant capacity (TAC) (<bold>b</bold>). Each value is the mean&#x02009;&#x000b1;&#x02009;standard error of the results (<italic>n</italic>&#x02009;=&#x02009;3, JC-1 assay; <italic>n</italic>&#x02009;=&#x02009;6, TAC assay). Statistical analysis was performed using the one-way ANOVA (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) and unpaired <italic>t</italic> test (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) for JC-1 assay and TAC assay, respectively. H<sub>2</sub>O<sub>2</sub>&#x02014;cells without HMB treatment and exposed to H<sub>2</sub>O<sub>2</sub>. H<sub>2</sub>O<sub>2</sub> + HMB&#x02014;cells treated with HMB and exposed to H<sub>2</sub>O<sub>2</sub></p></caption><graphic xlink:href="12263_2018_598_Fig9_HTML" id="MO9"/></fig></p><p id="Par59">Results obtained in a total antioxidant capacity (TAC) assay showed significant differences between HMB pre-treated and control group. Higher antioxidant capacity was observed in HMB pre-treated group (Fig.&#x000a0;<xref rid="Fig9" ref-type="fig">9b</xref>).</p></sec></sec><sec id="Sec19"><title>Discussion</title><p id="Par60">MicroRNAs are essential regulators for numerous biological processes by modulating gene expression at the post-transcriptional level. Several muscle-specific miRNAs (myomiRs) have been shown to play an important role in normal myoblast proliferation, differentiation, and muscle remodeling in response to different type of factors. Recent studies have begun to link miRNAs and certain muscle-related diseases [<xref ref-type="bibr" rid="CR21">21</xref>]. Modulation of miRNAs by dietary factors and miRNA-based gene therapies seems to be a promising option for the treatment of cardiac and skeletal muscle diseases [<xref ref-type="bibr" rid="CR22">22</xref>]. Among dietary additives, HMB seems to be an interesting potential myoprotectant for horses [<xref ref-type="bibr" rid="CR8">8</xref>]. Previous studies suggest that HMB may be involved in the regeneration processes of skeletal muscles [<xref ref-type="bibr" rid="CR23">23</xref>]. Moreover, HMB stimulates skeletal muscle satellite cell activation and may potentially increase skeletal muscle regenerative capacity after damage induction [<xref ref-type="bibr" rid="CR24">24</xref>].</p><p id="Par61">Our objective was to determine the influence of HMB on miRNA and gene expression in differentiating equine satellite cells subjected to damaging activity of hydrogen peroxide, as an in vitro model of short extreme effort-related muscle damage observed in racing and sport horses.</p><p id="Par62">Microarray analysis of total RNA in differentiating ESC incubated with HMB (24&#x000a0;h) and treated with H<sub>2</sub>O<sub>2</sub> (1&#x000a0;h) revealed the difference in the expression of 27 miRNAs (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>) and 4740 DEG (Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>: Table S1) from which 344 DET were chosen (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). Identified miRNAs and a large group of identified genes were previously described as these involved in the pathological and physiological processes in skeletal muscles as well as in other tissues. Selected miRNAs (miR-204 (&#x02191;), miR-208b (&#x02193;), miR-222 (&#x02191;), miR-675 (&#x02193;), miR-146a (&#x02191;), miR-146b (&#x02191;)) and genes (<italic>bdnf</italic> (&#x02193;), <italic>sod1</italic> (&#x02193;), <italic>sod2</italic> (&#x02191;), <italic>tgfb2</italic> (&#x02193;), <italic>myf5</italic> (&#x02193;), <italic>otud4</italic> (&#x02191;)) were validated by RT-qPCR showing the same trend as in microarray analysis.</p><sec id="Sec20"><title>HMB effects on miRNAs related to satellite/muscle cell proliferation and differentiation</title><p id="Par63">Of the 27 identified miRNAs, 9 are related to cell proliferation and 13 to differentiation in muscle tissue (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). Some of miRNAs seem to be particularly interesting in the context of previous publications confirming proven and potential HMB effect on muscle. Among them, family of miR-146a/b able to balance the induction of muscle proliferation or differentiation with miR-146 up- and downregulation, respectively [<xref ref-type="bibr" rid="CR25">25</xref>]. The miR-146a was one of the highest differentially expressed molecules showing 120.92 fold change in HMB-treated cells. It could suggest their possible involvement in promotion of HMB-induced myoblast proliferation. It is well-known that activation and proliferation of satellite cells is a prerequisite of skeletal muscle injury repair [<xref ref-type="bibr" rid="CR12">12</xref>], and it is possible that HMB is capable to influence miRNA expression, increasing myoblast proliferation rate and thus facilitating the myofiber regeneration. Similar observations were done for miR-133, in which upregulation was described as proliferation-inducing while its downregulation was responsible for differentiation progression [<xref ref-type="bibr" rid="CR26">26</xref>]. Interestingly, miRNA-222/221 which over-expression was noticed in myoblasts undergoing differentiation with its downregulation after differentiation [<xref ref-type="bibr" rid="CR27">27</xref>] was downregulated in ESC cultures exposed to H<sub>2</sub>O<sub>2</sub> and pretreated with HMB, when compared to control. The same expression trend (&#x02193;) was observed in miR-374b which over-expression is known to impair C2C12 cell differentiation, while inhibition promoted this process [<xref ref-type="bibr" rid="CR28">28</xref>]. Moreover, three miRNAs (miR-675, miR-324, and miR-331) known to be over-expressed in muscle cell differentiation [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>] were downregulated in our experiment. Two other miRNAs, miR-206 and miR-1, known to be downregulated in muscle cell proliferation and upregulated during differentiation [<xref ref-type="bibr" rid="CR31">31</xref>], have manifested downregulation in ESC cultures treated with HMB. Moreover, some of the identified miRNAs showed the opposite trend of expression change to this mentioned above (miR-1&#x02193;, miR-133&#x02193;, miR-206&#x02193;), promoting cell differentiation and proliferation in case of miRNA upregulation and downregulation, respectively. They were represented by miR-204 which was upregulated in differentiated human cardiomyocyte progenitor cells [<xref ref-type="bibr" rid="CR32">32</xref>] and miR-155 (&#x02191;) and miR-193a (&#x02191;), known to regulate cell differentiation in muscle cells [<xref ref-type="bibr" rid="CR33">33</xref>] and brown fat cells [<xref ref-type="bibr" rid="CR34">34</xref>], respectively. All of them possessed the same expression trend which was observed in our experiment in the case of HMB-treated group.</p><p id="Par64">The search of DET for the aforementioned miRNAs was done using Pathway Studio Web and has revealed a large group of genes involved in proliferation and differentiation, the processes previously described to be HMB modulated. The following cell proliferation-related genes were identified: <italic>jak2</italic> (target of identified miR-101, miR-155), <italic>rarg</italic> (miR-142-3p, miR-30c), <italic>pten</italic> (miR-146a, miR-374b, miR-193a), <italic>ets1</italic> (miR-221/222), and <italic>rarb</italic> (miR-146a, miR-146b); cell differentiation-related target genes: <italic>jak2</italic> (miR-155), <italic>pten</italic> (miR-1), <italic>klf4</italic> (miR-1, miR-146a, miR-206) and <italic>ets1</italic> (miR-221/222). Moreover, we identified several target genes which are involved in muscle organ development: <italic>sgcd</italic> (miR-142-3p), <italic>scd</italic> (miR-1, miR-128), <italic>cav3</italic> (miR-101), <italic>tcf12</italic> (miR-101, miR-142-3p, miR-155, miR-204, miR-208, miR-221/222), and <italic>col19a1</italic> (miR-1, miR-206), as modulated in ESC treated with HMB. Special attention deserves miR-206 together with described above miR-1 and miR-133 which regulate expression of one of its potential target genes <italic>cx43</italic> involved not only in muscle development but also in muscle regeneration where its upregulation was observed [<xref ref-type="bibr" rid="CR35">35</xref>]. The same expression trend of <italic>cx43</italic> was observed in our experiment in HMB-treated group. MiR-206 decreased expression in our experiment may be related to the fact that inhibition of miR-206 robustly increases myotube development [<xref ref-type="bibr" rid="CR36">36</xref>].</p><p id="Par65">Taken together, changes in expression of pro-proliferative (miR-133a/b, miR-146a/b, miR-222/221) and differentiation-related miRNAs (miR-1, miR-133a/b, miR-155, miR-193a, miR-204, miR-206, miR-221/222, miR-331, miR-324, miR-374, miR-675) were observed following HMB incubation and exposition of ESC cultures to H<sub>2</sub>O<sub>2</sub>, with concomitant changes in expression of their corresponding DET. These results, presenting the pro-proliferation and pro-differentiation effects of the aforementioned miRNAs, could be considered as contradictory, but in fact, both processes are important for proper myogenesis&#x02014;satellite cell proliferation necessary for proper myofiber regeneration manifested by myoblast fusion with damaged fibers or new myofiber formation, here shown at the very early stage of this process.</p></sec><sec id="Sec21"><title>HMB involvement in oxidative stress and inflammation</title><p id="Par66">In our study, we also observed HMB-related changes in the expression of miRNAs playing an important role in modulation of inflammation and oxidative stress. The acute inflammatory response is protective and stimulates repairing of injured tissue [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. The inflammatory infiltrate is a component of the satellite cell niche and also a source of locally released cytokines which regulate muscle regeneration.</p><p id="Par67">One of the most interesting miRNAs involved in oxidative stress and inflammation appears to be miR-146 family which members are known as negative regulators of inflammatory cytokine expression during immune response [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Curtale et al. [<xref ref-type="bibr" rid="CR39">39</xref>] showed that miR-146b may mediate anti-inflammatory activities and modulates the TLR4 signaling pathway by direct targeting several genes which are most likely targets for our identified miRNAs (<italic>cxcl10</italic>, <italic>tlr4</italic>). Their study also provides evidence for a link between miR-146b and IL-10, indicating that miR-146b induction depends on the activity of IL-10, which is suspected to be realized by muscle cells, both in vivo and in vitro [<xref ref-type="bibr" rid="CR40">40</xref>]. We did not observe changes in <italic>il-10</italic> mRNA expression in our experiment; however, other interleukin and cytokine gene expression was changed (e.g., <italic>il-5</italic>, <italic>il-6</italic>, <italic>il-13</italic>, <italic>il-15</italic>, <italic>il-18</italic>, <italic>cxcl10</italic>, and <italic>ccl11</italic>).</p><p id="Par68">In muscles, inflammatory response coincides with repair, regeneration, and growth, which involve activation and proliferation of satellite cells, followed by their terminal differentiation. Until now, limited number of data is available to distinguish features of muscle inflammation that promote injury from those that promote growth or repair of muscle. Moreover, dietary supplementation is known to be one of the ways to reduce skeletal and cardiac muscle damage by decreasing the inflammatory and oxidative stress response to exercise in sport horses [<xref ref-type="bibr" rid="CR41">41</xref>]. In muscles, anti-inflammatory substances (e.g., NSAIDs) are used to control excess local tissue damage by limiting proteolysis from infiltrating inflammatory cells [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. HMB has been suggested to inhibit inflammation [<xref ref-type="bibr" rid="CR44">44</xref>]. However, its anti-inflammatory mechanism is still not fully understood. Recent study conducted by Yakabe et al. [<xref ref-type="bibr" rid="CR44">44</xref>] suggested that HMB has anti-inflammatory potential by downregulation of IL-6 expression. Surprisingly, <italic>il-6</italic> was upregulated in our experiment (FC&#x02009;=&#x02009;20.01). Interestingly, the local production of IL-6 by skeletal muscle cells and stromal cells promotes activation of satellite cells, thereby increasing myotube regeneration [<xref ref-type="bibr" rid="CR45">45</xref>]. It is known that IL-6 mediates many aspects of the exercise-induced acute-phase response, including the upregulation of antioxidant defenses as response to oxidative stress [<xref ref-type="bibr" rid="CR46">46</xref>]. Similar to the aforementioned authors who demonstrated that miR-146b may inhibit pro-inflammatory cytokine secretion, we observed over-expression of both miR-146a and miR-146b. Moreover, miR-155, known to be an immunomodulatory miRNA, acts as a broad limiter of pro-inflammatory gene expression in muscle [<xref ref-type="bibr" rid="CR47">47</xref>] possessing the same trend which was observed in our experiment in the case of HMB-treated group. This, in turn, suggests that HMB may play an important role in the inflammation processes as an anti-inflammatory factor which could be related to the inhibition of pro-inflammatory cytokine secretion by HMB-induced miR-146 over-expression and activate innate immunity response by miR-155 over-expression.</p><p id="Par69">Interestingly, among DEG (several of them were classified as DET), a large group with the highest FC was involved in different kind of processes related to immunity-acute phase of inflammatory, activation of immunity cells, innate immunity, and pro-inflammatory activity (Table&#x000a0;<xref rid="Tab5" ref-type="table">5</xref>). Several of them (e.g., <italic>ccl11</italic>, <italic>ccl2</italic>, <italic>cxcl10</italic>, and <italic>saa1</italic>) were strongly upregulated, and this tendency was previously described as associated with pro-inflammatory activity status [<xref ref-type="bibr" rid="CR48">48</xref>] which is not fully consistent with tendency of identified in our experiment miRNA expression. Moreover, that a large group of DEG is involved in the inflammatory response and innate immune response in different kind of tissues (<italic>tlr3</italic>, <italic>tlr4</italic>, <italic>tlr10</italic>, <italic>cd40</italic>, <italic>cd44</italic>, <italic>igf2</italic>, <italic>itgb6</italic>, <italic>il-5</italic>, <italic>il-6</italic>, <italic>il-15</italic>, <italic>il</italic>-<italic>23</italic>, and a group of chemokine ligand: <italic>ccl-1</italic>, <italic>ccl-2</italic>, <italic>ccl-5</italic>, <italic>ccl-8</italic>). Both processes are necessary during regeneration, upon injury when immune cells rapidly infiltrate the muscle tissue to remove injured necrotic cells and secrete factors that are essential to activate satellite cells.<table-wrap id="Tab5"><label>Table 5</label><caption><p>Selected differentially expressed genes (DEG, with the highest FC) and biological processes which they were involved in</p></caption><table frame="hsides" rules="groups"><thead><tr><th>No.</th><th>Gene symbol</th><th>Regulation</th><th>Fold change</th><th>Description</th><th>Accession number</th><th>Related processes</th></tr></thead><tbody><tr><td>1</td><td>
<italic>cxcl2</italic>
</td><td>Up</td><td>76.31</td><td><italic>Equus caballus</italic> chemokine (C&#x02013;X&#x02013;C motif) ligand 2 (CXCL2)</td><td>[ENSECAT00000010991]</td><td>Expressed in regenerating muscle</td></tr><tr><td>2</td><td>
<italic>cxcl10</italic>
</td><td>Up</td><td>52.29</td><td><italic>Equus caballus</italic> chemokine (C&#x02013;X&#x02013;C motif) ligand 10</td><td>[NM_001114940]</td><td>Acute inflammation<break/>Acute skeletal muscle injury</td></tr><tr><td>3</td><td>
<italic>il-6</italic>
</td><td>Up</td><td>20.00</td><td><italic>Equus caballus</italic> interleukin 6 (interferon, beta 2) (IL6)</td><td>[NM_001082496]</td><td>Mediates the generation and elimination of ROS, stimulates SCs proliferation and hypertrophy</td></tr><tr><td>4</td><td>
<italic>ccl2</italic>
</td><td>Up</td><td>19.41</td><td><italic>Equus caballus</italic> chemokine (C&#x02013;C motif) ligand 2</td><td>[NM_001081931]</td><td>Acute inflammation<break/>Acute skeletal muscle injury</td></tr><tr><td>5</td><td>
<italic>tlr3</italic>
</td><td>Up</td><td>17.95</td><td><italic>Equus caballus</italic> Toll-like receptor 3 (TLR3)</td><td>[NM_001081798]</td><td>Oxidative stress, enhances cell viability</td></tr><tr><td>6</td><td>
<italic>saa1</italic>
</td><td>Up</td><td>16.80</td><td><italic>Equus caballus</italic> serum amyloid A1</td><td>[NM_001163892]</td><td>Acute phase response in skeletal muscle</td></tr><tr><td>7</td><td>
<italic>ccl5</italic>
</td><td>Up</td><td>11.74</td><td><italic>Equus caballus</italic> chemokine (C&#x02013;C motif) ligand 5 (CCL5)</td><td>[NM_001081863]</td><td>MAPK cascade, chronic inflammatory response</td></tr><tr><td>8</td><td>
<italic>ccl11</italic>
</td><td>Up</td><td>11.66</td><td><italic>Equus caballus</italic> chemokine (C&#x02013;C motif) ligand 11 (CCL11)</td><td>[NM_001081871]</td><td>Smooth muscle cell migration, chronic inflammatory response</td></tr><tr><td>9</td><td>
<italic>sod2</italic>
</td><td>Up</td><td>9.38</td><td><italic>Equus caballus</italic> superoxide dismutase 2</td><td>[NM_001082517]</td><td>Oxidative stress</td></tr><tr><td>10</td><td>
<italic>xaf1</italic>
</td><td>Up</td><td>7.80</td><td>XIAP-associated factor 1</td><td>[ENSECAT00000026936]</td><td>Apoptosis</td></tr><tr><td>11</td><td>
<italic>parp14</italic>
</td><td>Up</td><td>7.20</td><td>Poly(ADP-ribose) polymerase family member 14</td><td>[ENSECAT00000026964]</td><td>Muscle metabolism</td></tr><tr><td>12</td><td>
<italic>gsdmd</italic>
</td><td>Up</td><td>6.31</td><td>Gasdermin d</td><td>[ENSECAT00000015748]</td><td>Necrosis in inflammation, cell proliferation, induce apoptosis</td></tr><tr><td>13</td><td>
<italic>fgf7</italic>
</td><td>Up</td><td>5.83</td><td><italic>Equus caballus</italic> fibroblast growth factor 7 (FGF7)</td><td>[NM_001163883]</td><td>Participate in the proliferation of activated satellite cells via the Ras&#x02013;Raf&#x02013;MEK&#x02013;ERK signaling pathway</td></tr><tr><td>14</td><td>
<italic>jak2</italic>
</td><td>Up</td><td>5.14</td><td>Janus kinase 2</td><td>[ENSECAT00000010434]</td><td>Response to injury</td></tr><tr><td>15</td><td>
<italic>cd40</italic>
</td><td>Up</td><td>5.05</td><td><italic>Equus caballus</italic> CD40 molecule, TNF receptor superfamily member 5 (CD40)</td><td>[NM_001081902]</td><td>Humoral and cell-mediated immune responses, effective immune activation</td></tr><tr><td>16</td><td>
<italic>casp7</italic>
</td><td>Up</td><td>4.93</td><td>Caspase 7</td><td>[JL623025]</td><td>Muscle cell proliferation/survival</td></tr><tr><td>17</td><td>
<italic>psmb9</italic>
</td><td>Up</td><td>4.81</td><td>Proteasome (prosome, macropain) subunit, beta type, 9</td><td>[ENSECAT00000017937]</td><td>Muscle cell differentiation</td></tr><tr><td>18</td><td>
<italic>aox1</italic>
</td><td>Up</td><td>4.10</td><td><italic>Equus caballus</italic> aldehyde oxidase 1</td><td>[NM_001287267]</td><td>Muscle cell differentiation</td></tr></tbody></table></table-wrap></p><p id="Par70">The search of target genes for the identified aforementioned miRNAs has revealed a number of genes involved in innate immunity and processes accompanying inflammation, which HMB affects, represented by <italic>jak2</italic> (miR-101, miR-155), <italic>tlr4</italic> (miR-146a/b, miR-155), <italic>cxcl10</italic>, c<italic>xcl11</italic> (miR-146a/b), and <italic>cd47-</italic>target for oxidative stress and inflammation-related miRNAs (miR-221/222 and miR-155). HMB impact on the inflammatory processes and oxidative stress is not fully understood. However, our results show that this substance can modulate in the opposite way expression of pro- and anti-inflammatory miRNAs and genes. We assume this could be linked not only to the potential anti-inflammatory effect of HMB but also to the activation of early (innate) immune response (associated with H<sub>2</sub>O<sub>2</sub>-related damage), which is the initial phase of the regeneration process.</p></sec><sec id="Sec22"><title>MicroRNAs related to cell reaction to injury&#x02014;potential role of HMB as myoprotectant</title><p id="Par71">Among all identified miRNAs, several were known to be involved in cell reaction to injury and different phases of regeneration.</p><p id="Par72">MiR-675 seems to be one of the most interesting miRNAs which is the second of the most downregulated in HMB-treated group and is closely related to regeneration processes. Previous studies showed that miR-675 is expressed in skeletal muscles during myoblast differentiation and muscle regeneration [<xref ref-type="bibr" rid="CR29">29</xref>]. Another miRNA, miR-146, is related to satellite cell activation [<xref ref-type="bibr" rid="CR49">49</xref>], myoblast differentiation, and muscle regeneration in vivo [<xref ref-type="bibr" rid="CR50">50</xref>]. Moreover, also, miR-208 is known to be involved in injury-induced satellite cell activation [<xref ref-type="bibr" rid="CR51">51</xref>]. We suspect that HMB may stimulate and/or accelerate activation of equine satellite cells at very early stage of the regeneration process. These observations may suggest that HMB acting by the aforementioned miRNA induction may be involved in the satellite cell activation which accompanies regeneration. Hypertrophy is also an important phenomenon of regeneration process in muscle; however, it is related to the final stage of regeneration [<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par73">We identified several miRNAs that were previously described in relation to muscle hypertrophy. They were represented by downregulation in skeletal muscle hypertrophy miR-1 and miR-133a/b [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>] which possessed the same trend as was noticed in our experiment in the case of HMB-treated differentiating ESC cultures. Similar observation was done for miR-142 (&#x02193;), which as mentioned above presented one of the highest fold changes (FC&#x02009;=&#x02009;105.23) among the identified miRNAs, and its downregulation was described during cardiac hypertrophy and is able to inhibit cytokine signaling and function in the myocardium [<xref ref-type="bibr" rid="CR53">53</xref>]. It is possible that HMB incubation changes the expression of the aforementioned miRNAs facilitating for more efficient late regeneration (not observed during the first day after injury). More research is needed to evaluate the role of miR-133a/miR-1/miR-142-dependent hypertrophy mechanisms of HMB action in the activation of skeletal hypertrophy and muscle regeneration in different physiological and pathological conditions.</p><p id="Par74">Several potential target genes for identified miRNAs were classified as follow: hypertrophy: <italic>tpm3</italic> (miR-1, miR-206), <italic>tpm1</italic> (miR-142-5p), <italic>sgcd</italic> (miR-142-5p), <italic>cacnb1</italic> (miR-208b), <italic>itgav</italic> (miR-142-5p), <italic>itga2</italic> (miR-30c, miR-128); muscle regeneration-related processes and pathways: <italic>cx43</italic> (miR-206), <italic>klf4</italic> (miR-30<italic>c</italic>), and <italic>vegfc</italic> (miR-128, miR-133)<italic>.</italic></p></sec><sec id="Sec23"><title>Other HMB-related miRNAs and genes</title><p id="Par75">The effect of several identified in our experiment miRNAs in muscle tissue is still not clear. However, our results suggest that HMB modulates miRNA expression which was previously described in connection with various physiological and pathological conditions and could also be affected by HMB in injured muscle tissue: miR-374b&#x02014;related to lipid and protein metabolism [<xref ref-type="bibr" rid="CR54">54</xref>], miR-14&#x02014;regulator of mitochondria function in C2C12 [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>], miR-532-3p&#x02014;regulates mitochondrial fission in cardiac muscle [<xref ref-type="bibr" rid="CR57">57</xref>], miR-30c&#x02014;cellular adipogenesis and cardiac hypertrophy and ischemia [<xref ref-type="bibr" rid="CR58">58</xref>], miR-450a/c and miR-142&#x02014;negative regulators of cardiac hypertrophy [<xref ref-type="bibr" rid="CR59">59</xref>], and miR-542 family&#x02014;regeneration of various tissues [<xref ref-type="bibr" rid="CR60">60</xref>]. Interestingly, several identified genes (among them potential target genes for the aforementioned miRNAs) are also related to amino acid metabolism and protein ubiquitination and proteasome pathways (<italic>rnf6</italic>, <italic>cand2</italic>, <italic>ube2b</italic>, <italic>rnf138</italic>, <italic>rnf19b</italic>, <italic>rnf38</italic>, <italic>ube2l6</italic>, <italic>birc3</italic>, <italic>rnf114</italic>, <italic>mib1</italic>, <italic>trim36</italic>, and <italic>rnf4</italic>) which are closely related to the protein degradation during muscle atrophy in cachexia, and HMB is known to inhibit this process in humans and animals [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>].</p></sec><sec id="Sec24"><title>Target gene-related signaling pathways</title><p id="Par76">Furthermore, ontological analysis of miRNA DET revealed that a large group of genes was associated with biological processes and signaling pathways that are closely related to the muscle cell, muscle tissue development, and protein metabolism presented in Tables&#x000a0;<xref rid="Tab6" ref-type="table">6</xref> and&#x000a0;<xref rid="Tab7" ref-type="table">7</xref>, respectively.<table-wrap id="Tab6"><label>Table 6</label><caption><p>Selected biological processes identified in DAVID for differentially expressed target genes (DET)</p></caption><table frame="hsides" rules="groups"><thead><tr><th>No.</th><th>Biological processes</th><th>Number of identified genes</th><th>List of genes</th><th>FDR</th></tr></thead><tbody><tr><td>1</td><td>Muscle organ development</td><td>17</td><td><italic>six1</italic>, <italic>tiparp</italic>, <italic>acta1</italic>, <italic>cav3</italic>, <italic>cxcl10</italic>, <italic>col19a1</italic>, <italic>cxadr</italic>, <italic>foxp1</italic>, <italic>fxr1</italic>, <italic>mapk14</italic>, <italic>rarb</italic>, <italic>sgcd</italic>, <italic>zfand5</italic>, <italic>tcf12</italic>, <italic>tagln2</italic>, <italic>tpm1</italic>, <italic>zfpm2</italic></td><td>8.3E&#x02212;03</td></tr><tr><td>2</td><td>Modification-dependent protein catabolic process</td><td>27</td><td><italic>ube2g1</italic>, <italic>rnf217</italic>, <italic>edem3</italic>, <italic>edem1</italic>, <italic>otub2</italic>, <italic>cul3</italic>, <italic>fbxl19</italic>, <italic>rnf125</italic>, <italic>cyld</italic>, <italic>map1lc3b</italic>, <italic>rnf11</italic>, <italic>hectd1</italic>, <italic>ubr3</italic>, <italic>ube2h</italic>, <italic>mid1</italic>, <italic>hltf</italic>, <italic>trim63</italic>, <italic>march3</italic>, <italic>fem1c</italic>, <italic>dcun1d1</italic>, <italic>nedd4</italic>, <italic>rnf2</italic>, <italic>trim32</italic>, <italic>usp47</italic>, <italic>rnf138</italic>, <italic>cul4b</italic>, <italic>usp25</italic></td><td>1.4E&#x02212;01</td></tr><tr><td>3</td><td>Muscle cell differentiation</td><td>11</td><td><italic>tbx18</italic>, <italic>acta1</italic>, <italic>cav3</italic>, <italic>cxadr</italic>, <italic>foxp1</italic>,<italic>neo1</italic>, <italic>ntf3</italic>, <italic>rarb</italic>, <italic>sort1</italic>, <italic>syne1</italic>, <italic>tpm1</italic></td><td>2.5E&#x02212;01</td></tr><tr><td>4</td><td>Proteolysis involved in cellular catabolic process</td><td>27</td><td><italic>ube2g1</italic>, <italic>rnf217</italic>, <italic>edem3</italic>, <italic>edem1</italic>, <italic>otub2</italic>, <italic>cul3</italic>, <italic>fbxl19</italic>, <italic>rnf125</italic>, <italic>cyld</italic>, <italic>map1lc3b</italic>, <italic>rnf11</italic>, <italic>hectd1</italic>, <italic>ubr3</italic>, <italic>ube2h</italic>, <italic>mid1</italic>, <italic>hltf</italic>, <italic>trim63</italic>, <italic>march3</italic>, <italic>fem1c</italic>, <italic>dcun1d1</italic>, <italic>nedd4</italic>, <italic>rnf2</italic>, <italic>trim32</italic>, <italic>usp47</italic>, <italic>rnf138</italic>, <italic>cul4b</italic>,</td><td>2.8E&#x02212;01</td></tr><tr><td>5</td><td>Muscle tissue development</td><td>11</td><td><italic>six1</italic>, <italic>tpm1</italic>, <italic>tiparp</italic>, <italic>acta1</italic>, <italic>col19a1</italic>,<italic>cxadrp2</italic>, <italic>foxp1</italic>, <italic>mapk14</italic>, <italic>rarb</italic>, <italic>zfand5</italic>, <italic>zfpm2</italic></td><td>3.3E&#x02212;01</td></tr><tr><td>6</td><td>Protein catabolic process</td><td>27</td><td><italic>ube2g1</italic>, <italic>rnf217</italic>, <italic>edem3</italic>, <italic>edem1</italic>, <italic>otub2</italic>, <italic>cul3</italic>, <italic>fbxl19</italic>, <italic>rnf125</italic>, <italic>cyld</italic>, <italic>map1lc3b</italic>, <italic>rnf11</italic>, <italic>hectd1</italic>, <italic>ubr3</italic>, <italic>ube2h</italic>, <italic>mid1</italic>, <italic>hltf</italic>, <italic>trim63</italic>, <italic>march3</italic>, <italic>fem1c</italic>, <italic>dcun1d1</italic>, <italic>nedd4</italic>, <italic>rnf2</italic>, <italic>trim32</italic>, <italic>usp47</italic>, <italic>rnf138</italic>, <italic>cul4b</italic>, <italic>usp25</italic></td><td>4.8E&#x02212;01</td></tr><tr><td>7</td><td>Proteolysis</td><td>37</td><td><italic>ube2g1</italic>, <italic>rnf217</italic>, <italic>edem3</italic>, <italic>otub2</italic>, <italic>edem1</italic>, <italic>rnf125</italic>, <italic>cul3</italic>, <italic>fbxl19</italic>, <italic>cyld</italic>, <italic>ece1</italic>, <italic>map1lc3b</italic>, <italic>rnf11</italic>, <italic>dpp8</italic>, <italic>nsf</italic>, <italic>hectd1</italic>, <italic>capn6</italic>, <italic>nrip3</italic>, <italic>capn7</italic>, <italic>mmp19</italic>, <italic>ubr3</italic>, <italic>ube2h</italic>, <italic>mid1</italic>, <italic>hltf</italic>, <italic>trim63</italic>, <italic>march3</italic>, <italic>fem1c</italic>, <italic>dcun1d1</italic>, <italic>nedd4</italic>, <italic>rnf2</italic>, <italic>trim32</italic>, <italic>usp47</italic>, <italic>rnf138</italic>, <italic>tep1</italic>, <italic>nln</italic>, <italic>cul4b</italic>, <italic>usp25</italic>, <italic>adamts3</italic></td><td>1.6E&#x02212;00</td></tr><tr><td>8</td><td>Regulation of apoptosis</td><td>29</td><td><italic>ier3</italic>, <italic>cadm1</italic>, <italic>mcl1</italic>, <italic>tlr4</italic>, <italic>sgms1</italic>, <italic>mcf2l</italic>, <italic>slc11a2</italic>, <italic>cul3</italic>, <italic>map3k7</italic>, <italic>bdnf</italic>, <italic>tiam2</italic>, <italic>sos2</italic>, <italic>ngfrap1</italic>, <italic>faim</italic>, <italic>rarb</italic>, <italic>ip6k2</italic>, <italic>fgd4</italic>, <italic>traf3</italic>, <italic>rarg</italic>, <italic>ntf3</italic>, <italic>arhgef12</italic>, <italic>pla2g4a</italic>, <italic>eya1</italic>, <italic>tnfsf13b</italic>, <italic>dusp1</italic>, <italic>ets1</italic>, <italic>igf2r</italic>, <italic>sort1</italic>, <italic>jak2</italic></td><td>4.5E&#x02212;00</td></tr><tr><td>9</td><td>Positive regulation of cellular biosynthetic process</td><td>25</td><td><italic>tlr4</italic>, <italic>abca1</italic>, <italic>rarb</italic>, <italic>fam129a</italic>, <italic>znf423</italic>, <italic>rarg</italic>, <italic>epas1</italic>, <italic>ntf3</italic>, <italic>npr1</italic>, <italic>itga2</italic>, <italic>creb5</italic>, <italic>arntl</italic>, <italic>mecom</italic>, <italic>wwtr1</italic>, <italic>pla2g4a</italic>, <italic>ncoa1</italic>, <italic>sp1</italic>, <italic>ets1</italic>, <italic>mapk14</italic>, <italic>six1</italic>, <italic>pdgfra</italic>, <italic>jak2</italic>, <italic>zfpm2</italic>, <italic>smarca1</italic>, <italic>klf4</italic></td><td>8.3E&#x02212;00</td></tr><tr><td>10</td><td>Positive regulation of cell proliferation</td><td>16</td><td><italic>nampt</italic>, <italic>fgf7</italic>, <italic>itga2</italic>, <italic>vash2</italic>, <italic>foxp1</italic>, <italic>cxcl10</italic>, <italic>cul3</italic>, <italic>cd47</italic>, <italic>vegfc</italic>, <italic>pla2g4a</italic>, <italic>tnfsf13b</italic>, <italic>pdgfra</italic>, <italic>jak2</italic>, <italic>mab21l1</italic>, <italic>tbx18</italic>, <italic>pggt1b</italic></td><td>2.7E&#x02212;01</td></tr><tr><td>11</td><td>Positive regulation of inflammatory response</td><td>4</td><td><italic>jak2</italic>, <italic>itga2</italic>, <italic>pla2g4a</italic>, <italic>tlr4</italic></td><td>3.1E&#x02212;01</td></tr></tbody></table></table-wrap><table-wrap id="Tab7"><label>Table 7</label><caption><p>Selected pathways identified in DAVID for differentially expressed target genes (DET) and their corresponding miRNAs</p></caption><table frame="hsides" rules="groups"><thead><tr><th>No.</th><th>Pathway</th><th>Pathway <italic>P</italic> value</th><th>Number of genes</th><th>Gene name</th><th>Fold change</th><th>FDR</th><th>DET-related identified miRNA</th></tr></thead><tbody><tr><td rowspan="8">1</td><td rowspan="8">RIG-I-like receptor signalling pathway</td><td rowspan="8">5.2E&#x02212;04</td><td rowspan="8">8</td><td>
<italic>ddx3x</italic>
</td><td>1.59 &#x02191;</td><td>1.15E&#x02212;2</td><td>miR-101 &#x02191;, <bold>miR-1&#x02193;</bold>, <bold>miR-133a/b&#x02193;</bold>, <bold>miR-208&#x02193;</bold></td></tr><tr><td>
<italic>traf3</italic>
</td><td>1.31 &#x02191;</td><td>1.11E&#x02212;2</td><td><bold>miR-30&#x02193;</bold>, miR-155&#x02191;, <bold>miR-133a/b&#x02193;</bold></td></tr><tr><td>
<italic>cxcl10</italic>
</td><td>56.62 &#x02191;</td><td>2.16E&#x02212;5</td><td>
<bold>miR-142-3p&#x02193;</bold>
</td></tr><tr><td>
<italic>cyld</italic>
</td><td>1.78 &#x02191;</td><td>1.19E&#x02212;3</td><td><bold>miR-30&#x02193;</bold>, <bold>miR-133a/b&#x02193;</bold></td></tr><tr><td>
<italic>ikbke</italic>
</td><td>2.27 &#x02191;</td><td>2.44E&#x02212;3</td><td>miR-155&#x02191;, <bold>miR-128&#x02193;</bold></td></tr><tr><td>
<italic>mapk14</italic>
</td><td>1.68 &#x02191;</td><td>5.43E&#x02212;3</td><td><bold>miR-128&#x02193;</bold>, miR-101&#x02191;</td></tr><tr><td>
<italic>map3k7</italic>
</td><td>&#x02212;&#x02009;1.58 &#x02193;</td><td>4.02E&#x02212;3</td><td>miR-30&#x02193;, <bold>miR-101&#x02191;</bold>, <bold>miR-155&#x02191;</bold>, <bold>miR-204&#x02191;</bold></td></tr><tr><td>
<italic>rnf125</italic>
</td><td>1.88 &#x02191;</td><td>9.59E&#x02212;3</td><td>miR-101&#x02191;, <bold>miR-142-3p&#x02193;</bold></td></tr><tr><td rowspan="8">2</td><td rowspan="8">Hyper-trophy cardiomyopathy</td><td rowspan="8">1.5E&#x02212;03</td><td rowspan="8">8</td><td>
<italic>cacnb1</italic>
</td><td>&#x02212;&#x02009;1.42 &#x02193;</td><td>1.10E&#x02212;3</td><td><bold>miR-204&#x02191;</bold>, miR-208&#x02193;</td></tr><tr><td>
<italic>dag1</italic>
</td><td>&#x02212;&#x02009;1.91 &#x02193;</td><td>4.43E&#x02212;3</td><td>miR-142-3p&#x02193;, <bold>miR-101&#x02191;</bold>, miR-30&#x02193;</td></tr><tr><td>
<italic>itga2</italic>
</td><td>&#x02212;&#x02009;1.32 &#x02193;</td><td>7.08E&#x02212;3</td><td>miR-30&#x02193;, <bold>miR-101&#x02191;</bold>, miR-128&#x02193;</td></tr><tr><td>
<italic>itgav</italic>
</td><td>&#x02212;&#x02009;1.49 &#x02193;</td><td>6.71E&#x02212;3</td><td>miR-142-3p&#x02193;</td></tr><tr><td>
<italic>prkaa2</italic>
</td><td>&#x02212;&#x02009;1.69 &#x02193;</td><td>5.03E&#x02212;3</td><td>miR-30&#x02193;, <bold>miR-146a/b&#x02191;</bold></td></tr><tr><td>
<italic>sgcd</italic>
</td><td>1.33 &#x02191;</td><td>1.34E&#x02212;3</td><td>
<bold>miR-142-3p&#x02193;</bold>
</td></tr><tr><td>
<italic>tpm1</italic>
</td><td>&#x02212;&#x02009;1.85 &#x02193;</td><td>2.02E&#x02212;4</td><td>miR-142-3p&#x02193;, <bold>miR-542&#x02193;</bold></td></tr><tr><td>
<italic>tpm3</italic>
</td><td>&#x02212;&#x02009;2.87 &#x02193;</td><td>1.08E&#x02212;2</td><td><bold>miR-204&#x02191;</bold>, <bold>miR-221/222&#x02191;</bold></td></tr><tr><td rowspan="13">3</td><td rowspan="13">MAPK signalling pathway</td><td rowspan="13">7.3E&#x02212;03</td><td rowspan="13">13</td><td>
<italic>bdnf</italic>
</td><td>&#x02212;&#x02009;2.08 &#x02193;</td><td>9.14E&#x02212;4</td><td>miR-1&#x02193;, miR-206&#x02193;, <bold>miR-155&#x02191;</bold>, miR-30&#x02193;, <bold>miR-204&#x02191;</bold></td></tr><tr><td>
<italic>cacnb1</italic>
</td><td>&#x02212;&#x02009;1.42 &#x02193;</td><td>1.10E&#x02212;3</td><td><bold>miR-204&#x02191;</bold>, miR-208&#x02193;</td></tr><tr><td>
<italic>dusp1</italic>
</td><td>1.77 &#x02191;</td><td>2.80E&#x02212;3</td><td><bold>miR-133a/b&#x02193;</bold>, miR-101&#x02191;</td></tr><tr><td>
<italic>mecom</italic>
</td><td>1.50 &#x02191;</td><td>1.34E&#x02212;3</td><td><bold>miR-1&#x02193;</bold>, <bold>miR-133a/b&#x02193;</bold>, <bold>miR-206&#x02193;</bold>, <bold>miR-142-3p&#x02193;</bold></td></tr><tr><td>
<italic>fgf11</italic>
</td><td>&#x02212;&#x02009;1.36 &#x02193;</td><td>1.11E&#x02212;2</td><td>miR-331&#x02193;</td></tr><tr><td>
<italic>fgf7</italic>
</td><td>5.83 &#x02191;</td><td>2.33E&#x02212;3</td><td>miR-101&#x02191;, miR-155&#x02191;, <bold>miR-142-3p&#x02193;</bold></td></tr><tr><td>
<italic>mapk14</italic>
</td><td>1.68 &#x02191;</td><td>5.43E&#x02212;3</td><td><bold>miR-128&#x02193;</bold>, miR-101&#x02191;</td></tr><tr><td>
<italic>map3k7</italic>
</td><td>&#x02212;&#x02009;1.58 &#x02193;</td><td>4.02E&#x02212;3</td><td>miR-30&#x02193;, <bold>miR-101&#x02191;</bold>, <bold>miR-155&#x02191;</bold>, <bold>miR-204&#x02191;</bold></td></tr><tr><td>
<italic>map3k4</italic>
</td><td>&#x02212;&#x02009;1.36 &#x02193;</td><td>9.06E&#x02212;3</td><td><bold>miR-101&#x02191;</bold>, miR-128&#x02193;</td></tr><tr><td>
<italic>ntf3</italic>
</td><td>1.72 &#x02191;</td><td>2.44E&#x02212;3</td><td>miR-221/222&#x02191;</td></tr><tr><td>
<italic>pla2g4a</italic>
</td><td>2.27 &#x02191;</td><td>1.39E&#x02212;3</td><td>
<bold>miR-142-3p&#x02193;</bold>
</td></tr><tr><td>
<italic>dgfra</italic>
</td><td>2.82 &#x02191;</td><td>1.47E&#x02212;3</td><td>
<bold>miR-142-3p&#x02193;</bold>
</td></tr><tr><td>
<italic>sos2</italic>
</td><td>&#x02212;&#x02009;1.62 &#x02193;</td><td>9.09E&#x02212;3</td><td>miR-208&#x02193;, <bold>miR-204&#x02191;</bold>, <bold>miR-221/222&#x02191;</bold></td></tr><tr><td rowspan="4">4</td><td rowspan="4">p38 MAPK</td><td rowspan="4">9.9E&#x02212;02</td><td rowspan="4">4</td><td>
<italic>mapk14</italic>
</td><td>1.68 &#x02191;</td><td>5.43E&#x02212;3</td><td><bold>miR-128&#x02193;</bold>, miR-101&#x02191;</td></tr><tr><td>
<italic>map3k4</italic>
</td><td>&#x02212;&#x02009;1.36 &#x02193;</td><td>9.01E&#x02212;3</td><td><bold>miR-101&#x02191;</bold>, miR-128&#x02193;</td></tr><tr><td>
<italic>map3k7</italic>
</td><td>&#x02212;1.58 &#x02193;</td><td>4.02E&#x02212;3</td><td>miR-30&#x02193;, <bold>miR-101&#x02191;</bold>, <bold>miR-155&#x02191;</bold>, <bold>miR-204&#x02191;</bold></td></tr><tr><td>
<italic>dusp1</italic>
</td><td>1.77 &#x02191;</td><td>2.80E&#x02212;3</td><td><bold>miR-133a/b&#x02193;</bold>, miR-101&#x02191;</td></tr><tr><td rowspan="7">5</td><td rowspan="7">Toll-like receptor signalling pathway</td><td rowspan="7">1.6E&#x02212;02</td><td rowspan="7">7</td><td>
<italic>traf3</italic>
</td><td>1.31 &#x02191;</td><td>1.11E&#x02212;2</td><td>miR-30&#x02193;, <bold>miR-155&#x02191;</bold>, miR-133a/b&#x02193;</td></tr><tr><td>
<italic>cxcl10</italic>
</td><td>56.62 &#x02191;</td><td>2.16E&#x02212;5</td><td>
<bold>miR-142-3p&#x02193;</bold>
</td></tr><tr><td>
<italic>cxcl11</italic>
</td><td>14.20 &#x02191;</td><td>9.51E&#x02212;5</td><td><bold>miR-1</bold>&#x02193;, <bold>miR-206&#x02193;</bold></td></tr><tr><td>
<italic>tlr4</italic>
</td><td>1.44 &#x02191;</td><td>9.52E&#x02212;4</td><td><bold>miR-542&#x02193;</bold>, miR-374&#x02191;</td></tr><tr><td>
<italic>ikbke</italic>
</td><td>2.27 &#x02191;</td><td>2.44E&#x02212;3</td><td>miR-155&#x02191;, <bold>miR-128&#x02193;</bold></td></tr><tr><td>
<italic>mapk14</italic>
</td><td>1.68 &#x02191;</td><td>5.43E&#x02212;3</td><td><bold>miR-128&#x02193;</bold>, miR-101&#x02191;</td></tr><tr><td>
<italic>map3k7</italic>
</td><td>&#x02212;&#x02009;1.58 &#x02193;</td><td>4.02E&#x02212;3</td><td>miR-30&#x02193;, <bold>miR-101&#x02191;</bold>, <bold>miR-155&#x02191;</bold>, <bold>miR-204&#x02191;</bold></td></tr><tr><td rowspan="8">6</td><td rowspan="8">Ubiquitin-mediated proteolysis</td><td rowspan="8">2.0E&#x02212;02</td><td rowspan="8">8</td><td>
<italic>rhobtb2</italic>
</td><td>&#x02212;&#x02009;1.62 &#x02193;</td><td>9.15E&#x02212;3</td><td><bold>miR-204&#x02191;</bold>, miR-133&#x02193;</td></tr><tr><td>
<italic>cul3</italic>
</td><td>&#x02212;&#x02009;1.71 &#x02193;</td><td>4.76E&#x02212;5</td><td><bold>miR-101&#x02191;</bold>, <bold>miR-193a&#x02191;</bold></td></tr><tr><td>
<italic>cul4b</italic>
</td><td>1.58 &#x02191;</td><td>1.08E&#x02212;3</td><td>miR-133a/b&#x02193;, <bold>miR-101&#x02191;</bold></td></tr><tr><td>
<italic>mid1</italic>
</td><td>&#x02212;&#x02009;1.40 &#x02193;</td><td>1.01E&#x02212;2</td><td>miR-374&#x02193;, miR-542-3p&#x02193;</td></tr><tr><td>
<italic>nedd4</italic>
</td><td>&#x02212;&#x02009;1.30 &#x02193;</td><td>1.00E&#x02212;2</td><td>miR-30&#x02193;, miR-128&#x02193;</td></tr><tr><td>
<italic>trim32</italic>
</td><td>1.50 &#x02191;</td><td>1.13E&#x02212;2</td><td>miR-155&#x02191;, <bold>miR-142-3p&#x02193;</bold></td></tr><tr><td>
<italic>ube2g1</italic>
</td><td>&#x02212;&#x02009;1.41 &#x02193;</td><td>5.46E&#x02212;4</td><td><bold>miR-101&#x02191;</bold>, miR-30&#x02193;,</td></tr><tr><td>
<italic>ube2h</italic>
</td><td>&#x02212;&#x02009;1.53 &#x02193;</td><td>3.80E&#x02212;3</td><td>miR-1&#x02193;, miR-206&#x02193;, <bold>miR-204&#x02191;</bold>, <bold>miR-101&#x02191;</bold></td></tr><tr><td rowspan="6">7</td><td rowspan="6">Ras pathway</td><td rowspan="6">3.4E&#x02212;02</td><td rowspan="6">6</td><td>
<italic>tiam2</italic>
</td><td>&#x02212;&#x02009;1.44 &#x02193;</td><td>3.27E&#x02212;3</td><td>
<bold>miR-101&#x02191;</bold>
</td></tr><tr><td>
<italic>sos2</italic>
</td><td>&#x02212;&#x02009;1.54 &#x02193;</td><td>9.09E&#x02212;3</td><td><bold>miR-193&#x02191;</bold>, miR-208&#x02193;,</td></tr><tr><td>
<italic>ets1</italic>
</td><td>1.98 &#x02191;</td><td>7.19E&#x02212;3</td><td>miR-193&#x02191;, miR-208&#x02191;, miR-101&#x02191;, miR-221/222&#x02191;, <bold>miR-1&#x02193;</bold>, <bold>miR-206&#x02193;</bold></td></tr><tr><td>
<italic>mapk14</italic>
</td><td>1.68 &#x02191;</td><td>5.43E&#x02212;3</td><td><bold>miR-128&#x02193;</bold>, miR-101&#x02191;</td></tr><tr><td>
<italic>map3k7</italic>
</td><td>&#x02212;&#x02009;1.58 &#x02193;</td><td>4.02E&#x02212;3</td><td>miR-30&#x02193;, <bold>miR-101&#x02191;</bold>, <bold>miR-155&#x02191;</bold>, <bold>miR-204&#x02191;</bold></td></tr><tr><td>
<italic>map3k4</italic>
</td><td>&#x02212;&#x02009;1.36 &#x02193;</td><td>9.01E3</td><td><bold>miR-101&#x02191;</bold>, miR-128&#x02193;</td></tr><tr><td rowspan="5">8</td><td rowspan="5">Oxidative stress response</td><td rowspan="5">3.9E&#x02212;02</td><td rowspan="5">5</td><td>
<italic>dusp1</italic>
</td><td>1.77 &#x02191;</td><td>2.80E&#x02212;3</td><td><bold>miR-133a/b&#x02193;</bold>, miR-101&#x02191;</td></tr><tr><td>
<italic>dusp19</italic>
</td><td>&#x02212;&#x02009;1.55 &#x02193;</td><td>2.09E&#x02212;3</td><td>
<bold>miR-204&#x02191;</bold>
</td></tr><tr><td>
<italic>mapk14</italic>
</td><td>1.68 &#x02191;</td><td>5.43E&#x02212;3</td><td><bold>miR-128&#x02193;</bold>, miR-101&#x02191;</td></tr><tr><td>
<italic>map3k4</italic>
</td><td>&#x02212;&#x02009;1.36 &#x02193;</td><td>9.01E&#x02212;3</td><td><bold>miR-101&#x02191;</bold>, miR-128&#x02193;</td></tr><tr><td>
<italic>pla2g4a</italic>
</td><td>2.27 &#x02191;</td><td>1.39E&#x02212;3</td><td>
<bold>miR-142-3p&#x02193;</bold>
</td></tr></tbody></table><table-wrap-foot><p>MiRNAs in bold have the opposite expression change to corresponding DET. The arrows indicate the direction of expression change: &#x02193; and &#x02191; for down- and upregulation, respectively</p></table-wrap-foot></table-wrap></p><p id="Par77">Among the most strongly regulated pathways were these previously described as engaged in immunity and inflammation: Toll-like receptor, RIG-I, Ras, MAPK, and ubiquitin-mediated proteolysis. Toll-like receptor pathway is related to the inflammatory activity [<xref ref-type="bibr" rid="CR61">61</xref>] and different kind of myopathies and could be modulated by miR-155 [<xref ref-type="bibr" rid="CR62">62</xref>]. RIG-I-like receptor pathway is known to play a crucial role in innate response [<xref ref-type="bibr" rid="CR63">63</xref>] which is necessary to activate early muscle regeneration and may be modulated by three identified miRNAs: miR-146a, miR-146b, and miR-155. Ras and MAPK pathways promote protein degradation in muscle cells [<xref ref-type="bibr" rid="CR64">64</xref>] and oxidative stress (closely related to miR-146 activity) [<xref ref-type="bibr" rid="CR61">61</xref>]. Moreover, MAPK pathway plays a pivotal role in the energy metabolism through modulating lipid metabolism, skeletal muscle growth, and different kind of muscular myopathies and atrophy [<xref ref-type="bibr" rid="CR65">65</xref>]. Finally, ubiquitin-mediated proteolysis identified as a potential target gene-related pathway is closely related to muscle atrophy by protein degradation.</p></sec><sec id="Sec25"><title>Western blot analysis&#x02014;HMB protective effect on proteins</title><p id="Par78">Western blot analysis was performed to check the level of proteins corresponding with several genes and miRNA. However, the results that were obtained are impossible to use in this way. It is related to the protein degradation which is strongly linked to hydrogen peroxide effect. Previous studies related to hydrogen peroxide effect on different kind of proteins showed that this substance cause protein degradation. For example, exposure of skeletal muscle myotubes to ROS (i.e., hydrogen peroxide) can activate proteases leading to protein degradation as it was described by Li et al. [<xref ref-type="bibr" rid="CR21">21</xref>] and Clung et al. [<xref ref-type="bibr" rid="CR55">55</xref>]. Finnegan et al. [<xref ref-type="bibr" rid="CR9">9</xref>] observed the interactions of a liquid and gaseous H<sub>2</sub>O<sub>2</sub> with amino acids and proteins (bovine serum albumin and aldolase). In this study, authors observed that two dosages of hydrogen peroxide cause total degradation of BSA (the absence of bands). In our study, we observed similar situation. We checked three different housekeeping genes: &#x003b2;-actin, <italic>gapdh</italic>, and &#x003b1;-tubulin. For all of them, we noticed the same trend of protein degradation in samples where the cells were exposed to hydrogen peroxide (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>). Moreover, we checked several different proteins where we also noticed protein degradation on a similar level as in samples mentioned above. We suspect that samples where the cells were previously incubated with HMB were protected from protein degradation related to hydrogen peroxide. This degradation has already occurred at the cellular level, not during the sample preparation for western blotting. During the sample preparation procedure, we used RIPA buffer with protease inhibitor cocktail. Based on this observation and previous studies [<xref ref-type="bibr" rid="CR66">66</xref>&#x02013;<xref ref-type="bibr" rid="CR68">68</xref>] related to HMB, we think that this substance may decrease protein degradation in equine satellite cells exposed to hydrogen peroxide; however, the comparison of protein levels between experimental and control conditions is impossible.</p></sec><sec id="Sec26"><title>Cell viability, cell damage, and oxidative stress</title><p id="Par79">Five different tests were performed to check the effect of potential antioxidant properties of HMB and its cell protection activity. Based on our results from the test where we observed direct cell oxidative stress together with typical damage (lipid peroxidation together with mitochondria activity changes) related to oxidative stress, it cannot be unambiguously determined whether HMB in experimental dosage has properties that limit oxidative stress (Figs.&#x000a0;<xref rid="Fig8" ref-type="fig">8a, b</xref> and <xref rid="Fig9" ref-type="fig">9a</xref>). However, we observed that HMB increase total antioxidant capacity (Fig.&#x000a0;<xref rid="Fig9" ref-type="fig">9</xref>b). According to our knowledge, there are limited data considering direct antioxidant activity of HMB; however, as it was mentioned, our study revealed several miRNAs, genes, and pathways related to oxidative stress and antioxidant activity which were modulated by HMB. Increased total antioxidant capacity may represent an adaptive response to the enhanced generation of ROS related to hydrogen peroxide activity or likely responsible for the attenuation of oxidative damage.</p><p id="Par80">Two independent tests showed that HMB increased cell viability: MTT and SYTOX Red Dead Cell (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>). These observations are consistent with the study presented by Vallejo et al. [<xref ref-type="bibr" rid="CR69">69</xref>]. Authors also observed that HMB enhanced myoblast viability (in C2C12 cell line). Moreover, earlier study by Pacini et al. [<xref ref-type="bibr" rid="CR70">70</xref>] showed that HMB significantly prevented dexamethasone-induced cell mortality. Based on our results, we think that HMB may prevents cells from the hydrogen peroxide-induced mortality and enhance ESC&#x02019;s viability.</p></sec></sec><sec id="Sec27"><title>Conclusions</title><p id="Par81">Our study presents several new findings of the mechanisms of action of HMB and its potential role in muscle physiology and pathology. We focused on HMB-induced miRNA expression changes previously described as those associated with the muscle tissue injury (inflammation), regeneration, and the accompanying processes such as cell activation, proliferation, migration, and differentiation. The scheme of putative mode of miRNAs and DEG-depended HMB action is proposed in Fig.&#x000a0;<xref rid="Fig10" ref-type="fig">10</xref>.<fig id="Fig10"><label>Fig. 10</label><caption><p>Potential role of HMB-induced miRNAs and selected target genes in muscle regeneration process</p></caption><graphic xlink:href="12263_2018_598_Fig10_HTML" id="MO10"/></fig></p><p id="Par82">We demonstrated for the first time that HMB-treated equine satellite cells exposed to H<sub>2</sub>O<sub>2</sub> have modulated expression of 27 miRNAs which could affect the abovementioned processes. Many of them were not known for being differentially expressed during myogenic proliferation, differentiation, or processes related to muscle injury and activation in early stage of regeneration. That is why, it would also be interesting to investigate whether some of the abovementioned miRNAs participate in skeletal muscle degeneration/regeneration process as well as degeneration-related equine muscular diseases, such as muscle inflammation related to the extreme effort or recurrent rhabdomyopathy.</p><p id="Par83">Moreover, we found DET for identified HMB-modulated miRNAs which are related to key processes in muscle physiology and pathology. Also, identified pathways MAPK, Ras, and RIG-I together with those involved in oxidative stress response seem to support our knowledge about the potential mechanisms of HMB action. Based on the obtained results, we also believe that HMB increases the survival of cells treated with hydrogen peroxide. Further analyses evaluating the effect of HMB on injured, recovering muscle tissue are needed to verify the collected data.</p></sec><sec sec-type="supplementary-material"><title>Additional files</title><sec id="Sec28"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12263_2018_598_MOESM1_ESM.xlsx"><label>Additional file 1:</label><caption><p><bold>Table S1.</bold> Genes differentially expressed in HMB-incubated equine satellite cells exposed to H<sub>2</sub>O<sub>2</sub>, compared to control. FDR&#x02009;&#x02264;&#x02009;0.05, FC&#x02009;&#x02265;&#x02009;1.3, <italic>n</italic>&#x02009;=&#x02009;4. (XLSX 550&#x000a0;kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="12263_2018_598_MOESM2_ESM.xlsx"><label>Additional file 2:</label><caption><p><bold>Table S2.</bold> Biological function of differentially expressed genes (DEG). (XLSX 28&#x000a0;kb)</p></caption></media></supplementary-material>
</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>CTRL</term><def><p id="Par5">Control condition</p></def></def-item><def-item><term>DEG</term><def><p id="Par6">Differentially expressed genes</p></def></def-item><def-item><term>DET</term><def><p id="Par7">Differentially expressed target genes</p></def></def-item><def-item><term>DM</term><def><p id="Par8">Differentiation medium</p></def></def-item><def-item><term>DMSO</term><def><p id="Par9">Dimethylsulfoxide</p></def></def-item><def-item><term>ESCs</term><def><p id="Par10">Equine satellite cells</p></def></def-item><def-item><term>FBS</term><def><p id="Par11">Fetal bovine serum</p></def></def-item><def-item><term>GE</term><def><p id="Par12">Gene expression</p></def></def-item><def-item><term>GM</term><def><p id="Par13">Growth medium</p></def></def-item><def-item><term>HMB</term><def><p id="Par14">&#x003b2;-Hydroxy-&#x003b2;-methylbutyrate</p></def></def-item><def-item><term>HS</term><def><p id="Par15">Horse serum</p></def></def-item><def-item><term>IB</term><def><p id="Par16">Incubation buffer</p></def></def-item><def-item><term>PBS</term><def><p id="Par17">Phosphate<italic>-</italic>buffered saline</p></def></def-item><def-item><term>ROS</term><def><p id="Par18">Reactive oxygen species</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Electronic supplementary material</bold></p><p>The online version of this article (10.1186/s12263-018-0598-2) contains supplementary material, which is available to authorized users.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors would like to thank Dr. Ma&#x00142;gorzata Gajewska and Emmanuel Gonzalez Escobar for their help in preparing the manuscript.</p><sec id="FPar1"><title>Funding</title><p id="Par84">This research was funded by National Science Centre (Poland), Grant No. 2011/03/B/NZ5/05697. Publication of this manuscript was supported by KNOW (Leading National Research Centre) Scientific Consortium &#x0201c;Healthy Animal - Safe Food,&#x0201d; decision of the Ministry of Science and Higher Education No. 05-1/KNOW2/2015.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p id="Par85">All data generated or analyzed during this study are included in this published article (and its additional files).</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>KCH carried out the muscle sampling, cell viability, oxidative stress and lipid peroxidation assays, RT-qPCR validation of microarray results, western blot, ontological analysis, and interpretation of the obtained data and wrote the manuscript. AC carried out the equine satellite cell isolation and culture, RNA isolation and microarray analysis, and western blot. KM carried out the flow cytometry analysis and data interpretation. PO participated in the study design and helped in the manuscript revision. TS participated in the study design; supervised the project; performed the muscle sampling, statistical analyses of microarray and RT-qPCR data, cell viability, oxidative stress, and lipid peroxidation; assisted in the manuscript preparation and revision; and prepared the figures. All authors read and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar3"><title>Ethics approval and consent to participate</title><p id="Par86">This study complies with the national and institutional guidelines of the use of animals in research according to the Polish legal act from January 21, 2005. Since sample collection was performed during the routine slaughter and no additional procedures that would be harmful and painful for animals were applied, this study did not require formal ethics approval.</p></sec><sec id="FPar4"><title>Consent for publication</title><p id="Par87">Not applicable.</p></sec><sec id="FPar5"><title>Competing interests</title><p id="Par88">The authors declare that they have no competing interests.</p></sec><sec id="FPar6"><title>Publisher&#x02019;s Note</title><p id="Par89">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Koevering</surname><given-names>MT</given-names></name><name><surname>Dolezal</surname><given-names>HG</given-names></name><name><surname>Gill</surname><given-names>DR</given-names></name><name><surname>Owens</surname><given-names>FN</given-names></name><name><surname>Strasia</surname><given-names>CA</given-names></name><name><surname>Buchanan</surname><given-names>DS</given-names></name><name><surname>Lake</surname><given-names>R</given-names></name><name><surname>Nissen</surname><given-names>S</given-names></name></person-group><article-title>Effects of beta-hydroxy-beta-methyl butyrate on performance and carcass quality of feedlot steers</article-title><source>J Anim Sci</source><year>1994</year><volume>72</volume><fpage>1927</fpage><lpage>1935</lpage><pub-id pub-id-type="doi">10.2527/1994.7281927x</pub-id><pub-id pub-id-type="pmid">7982819</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aversa</surname><given-names>Z</given-names></name><name><surname>Bonetto</surname><given-names>A</given-names></name><name><surname>Costelli</surname><given-names>P</given-names></name><name><surname>Minero</surname><given-names>VG</given-names></name><name><surname>Penna</surname><given-names>F</given-names></name><name><surname>Baccino</surname><given-names>FM</given-names></name><name><surname>Lucia</surname><given-names>S</given-names></name><name><surname>Rossi Fanelli</surname><given-names>F</given-names></name><name><surname>Muscaritoli</surname><given-names>M</given-names></name></person-group><article-title>&#x000df;-Hydroxy-&#x000df;-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia</article-title><source>Int J Oncol</source><year>2011</year><volume>38</volume><fpage>713</fpage><lpage>720</lpage><pub-id pub-id-type="pmid">21184031</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szcze&#x0015b;niak</surname><given-names>KA</given-names></name><name><surname>Ostaszewski</surname><given-names>P</given-names></name><name><surname>Fuller</surname><given-names>JC</given-names></name><name><surname>Ciecierska</surname><given-names>A</given-names></name><name><surname>Sadkowski</surname><given-names>T</given-names></name></person-group><article-title>Dietary supplementation of &#x003b2;-hydroxy-&#x003b2;-methylbutyrate in animals&#x02014;a review</article-title><source>J Anim Physiol Anim Nutr</source><year>2015</year><volume>99</volume><issue>3</issue><fpage>405</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1111/jpn.12234</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norton</surname><given-names>LE</given-names></name><name><surname>Layman</surname><given-names>DK</given-names></name></person-group><article-title>Leucine regulates translation initiation of protein synthesis in skeletal muscle after exercise</article-title><source>J Nutr</source><year>2006</year><volume>136</volume><fpage>533S</fpage><lpage>537S</lpage><pub-id pub-id-type="doi">10.1093/jn/136.2.533S</pub-id><pub-id pub-id-type="pmid">16424142</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panton</surname><given-names>LB</given-names></name><name><surname>Rathmacher</surname><given-names>JA</given-names></name><name><surname>Baier</surname><given-names>S</given-names></name><name><surname>Nissen</surname><given-names>S</given-names></name></person-group><article-title>Nutritional supplementation of the leucine metabolite &#x003b2;-hydroxy-&#x003b2;-methylbutyrate (HMB) during resistance training</article-title><source>Nutrition</source><year>2000</year><volume>16</volume><fpage>734</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1016/S0899-9007(00)00376-2</pub-id><pub-id pub-id-type="pmid">10978853</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deutz</surname><given-names>NE</given-names></name><name><surname>Pereira</surname><given-names>SL</given-names></name><name><surname>Hays</surname><given-names>NP</given-names></name><name><surname>Oliver</surname><given-names>JS</given-names></name><name><surname>Edens</surname><given-names>NK</given-names></name><name><surname>Evans</surname><given-names>CM</given-names></name><name><surname>Wolfe</surname><given-names>RR</given-names></name></person-group><article-title>Effect of &#x003b2;-hydroxy-&#x003b2;-methylbutyrate (HMB) on lean body mass during 10 days of bed rest in older adults</article-title><source>Clin Nutr</source><year>2013</year><volume>32</volume><fpage>704</fpage><lpage>712</lpage><pub-id pub-id-type="doi">10.1016/j.clnu.2013.02.011</pub-id><pub-id pub-id-type="pmid">23514626</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Someren</surname><given-names>KA</given-names></name><name><surname>Edwards</surname><given-names>AJ</given-names></name><name><surname>Howatson</surname><given-names>G</given-names></name></person-group><article-title>Supplementation with [beta]-hydroxy-[beta]-methylbutyrate (HMB) and [alpha]-ketoisocaproic acid (KIC) reduces signs and symptoms of exercise-induced muscle damage in man</article-title><source>Int J Sport Nutr Exerc Metab</source><year>2005</year><volume>15</volume><fpage>413</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1123/ijsnem.15.4.413</pub-id><pub-id pub-id-type="pmid">16286672</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostaszewski</surname><given-names>P</given-names></name><name><surname>Kowalska</surname><given-names>A</given-names></name><name><surname>Szarska</surname><given-names>E</given-names></name><name><surname>Szpota&#x00144;ski</surname><given-names>P</given-names></name><name><surname>Cywinska</surname><given-names>A</given-names></name><name><surname>Ba&#x00142;asi&#x00144;ska</surname><given-names>B</given-names></name><name><surname>Sadkowski</surname><given-names>T</given-names></name></person-group><article-title>Effects of &#x003b2;-hydroxy-&#x003b2;-methylbutyrate and &#x003b3;-oryzanol on blood biochemical markers in exercising thoroughbred race horses</article-title><source>J Equine Vet Sci</source><year>2012</year><volume>32</volume><fpage>542</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.1016/j.jevs.2012.01.002</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finnegan</surname><given-names>M</given-names></name><name><surname>Linley</surname><given-names>E</given-names></name><name><surname>Denyer</surname><given-names>SP</given-names></name><name><surname>McDonnell</surname><given-names>G</given-names></name><name><surname>Simons</surname><given-names>C</given-names></name><name><surname>Maillard</surname><given-names>JY</given-names></name></person-group><article-title>Mode of action of hydrogen peroxide and other oxidizing agents: differences between liquid and gas forms</article-title><source>J Antimicrob Chemother</source><year>2010</year><volume>65</volume><issue>10</issue><fpage>2108</fpage><lpage>2115</lpage><pub-id pub-id-type="doi">10.1093/jac/dkq308</pub-id><pub-id pub-id-type="pmid">20713407</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname><given-names>DM</given-names></name><name><surname>Copp</surname><given-names>SW</given-names></name><name><surname>Schwagerl</surname><given-names>PJ</given-names></name><name><surname>Musch</surname><given-names>TI</given-names></name><name><surname>Poole</surname><given-names>DC</given-names></name></person-group><article-title>Acute effects of hydrogen peroxide on skeletal muscle microvascular oxygenation from rest to contractions</article-title><source>J Appl Physiol</source><year>2011</year><volume>110</volume><fpage>1290</fpage><lpage>1298</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.01489.2010</pub-id><pub-id pub-id-type="pmid">21372096</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoi</surname><given-names>W</given-names></name><name><surname>Naito</surname><given-names>Y</given-names></name><name><surname>Takanami</surname><given-names>Y</given-names></name><name><surname>Kawai</surname><given-names>Y</given-names></name><name><surname>Sakuma</surname><given-names>K</given-names></name><name><surname>Ichikawa</surname><given-names>H</given-names></name><name><surname>Yoshida</surname><given-names>N</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name></person-group><article-title>Oxidative stress and delayed-onset muscle damage after exercise</article-title><source>Free Radic Biol Med</source><year>2004</year><volume>37</volume><fpage>480</fpage><lpage>487</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2004.05.008</pub-id><pub-id pub-id-type="pmid">15256219</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciecierska</surname><given-names>A</given-names></name><name><surname>Chodkowska</surname><given-names>K</given-names></name><name><surname>Motyl</surname><given-names>T</given-names></name><name><surname>Sadkowski</surname><given-names>T</given-names></name></person-group><article-title>Myogenic cells applications in regeneration of post-infarction cardiac tissue</article-title><source>J Physiol Pharmacol</source><year>2013</year><volume>64</volume><fpage>401</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">24101386</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van der Meer</surname><given-names>SF</given-names></name><name><surname>Jaspers</surname><given-names>RT</given-names></name><name><surname>Jones</surname><given-names>DA</given-names></name><name><surname>Degens</surname><given-names>H</given-names></name></person-group><article-title>The time course of myonuclear accretion during hypertrophy in young adult and older rat plantaris muscle</article-title><source>Ann Anat</source><year>2011</year><volume>193</volume><issue>1</issue><fpage>56</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.aanat.2010.08.004</pub-id><pub-id pub-id-type="pmid">20833519</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovanda</surname><given-names>A</given-names></name><name><surname>Re&#x0017e;en</surname><given-names>T</given-names></name><name><surname>Rogelj</surname><given-names>B</given-names></name></person-group><article-title>MicroRNA in skeletal muscle development, growth, atrophy, and disease</article-title><source>Wiley Interdiscip Rev RNA</source><year>2014</year><volume>5</volume><issue>4</issue><fpage>509</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1002/wrna.1227</pub-id><pub-id pub-id-type="pmid">24838768</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szcze&#x0015b;niak</surname><given-names>KA</given-names></name><name><surname>Ciecierska</surname><given-names>A</given-names></name><name><surname>Ostaszewski</surname><given-names>P</given-names></name><name><surname>Sadkowski</surname><given-names>T</given-names></name></person-group><article-title>Characterisation of equine satellite cell transcriptomic profile response to &#x003b2;-hydroxy-&#x003b2;-methylbutyrate (HMB)</article-title><source>Br J Nutr</source><year>2016</year><volume>116</volume><issue>8</issue><fpage>1315</fpage><pub-id pub-id-type="doi">10.1017/S000711451600324X</pub-id><pub-id pub-id-type="pmid">27691998</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55.</mixed-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostaszewski</surname><given-names>P</given-names></name><name><surname>Kostiuk</surname><given-names>S</given-names></name><name><surname>Balasi&#x00144;ska</surname><given-names>B</given-names></name><name><surname>Jank</surname><given-names>M</given-names></name><name><surname>Papet</surname><given-names>I</given-names></name><name><surname>Glomot</surname><given-names>F</given-names></name></person-group><article-title>The leucine metabolite 3-hydroxy-3-methylbutyrate (HMB) modifies protein turnover in muscles of laboratory rats and domestic chickens in vitro</article-title><source>J Anim Physiol Anim Nutr</source><year>2000</year><volume>84</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1046/j.1439-0396.2000.00272.x</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="other">Szcze&#x0015b;niak KA, Ciecierska A, Ostaszewski P, Sadkowski T. Transcriptomic profile adaptations following exposure of equine satellite cells to nutriactive phytochemical gamma-oryzanol. Genes Nutr 2016;11(1):1.</mixed-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimson</surname><given-names>A</given-names></name><name><surname>Farh</surname><given-names>KK</given-names></name><name><surname>Johnston</surname><given-names>WK</given-names></name><name><surname>Garrett-Engele</surname><given-names>P</given-names></name><name><surname>Lim</surname><given-names>LP</given-names></name><name><surname>Bartel</surname><given-names>DP</given-names></name></person-group><article-title>MicroRNA targeting specificity in mammals: determinants beyond seed pairing</article-title><source>Mol Cell</source><year>2007</year><volume>27</volume><issue>1</issue><fpage>91</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2007.06.017</pub-id><pub-id pub-id-type="pmid">17612493</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="other">Zielniok K, Motyl T, Gajewska M. Functional interactions between 17&#x003b2;-estradiol and progesterone regulate autophagy during acini formation by bovine mammary epithelial cells in 3D cultures. Biomed Res Int. 2014;2014. Article ID 382653. 10.1155/2014/382653.</mixed-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>YP</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>AS</given-names></name><name><surname>Reid</surname><given-names>MB</given-names></name></person-group><article-title>Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes</article-title><source>Am J Physiol Cell Physiol</source><year>2003</year><volume>285</volume><issue>4</issue><fpage>C806</fpage><lpage>C812</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00129.2003</pub-id><pub-id pub-id-type="pmid">12773310</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasiakos</surname><given-names>SM</given-names></name><name><surname>McClung</surname><given-names>JP</given-names></name></person-group><article-title>MiRNA analysis for the assessment of exercise and amino acid effects on human skeletal muscle</article-title><source>Adv Nutr</source><year>2013</year><volume>4</volume><issue>4</issue><fpage>412</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.3945/an.113.003699</pub-id><pub-id pub-id-type="pmid">23858090</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jowko</surname><given-names>E</given-names></name><name><surname>Ostaszewski</surname><given-names>P</given-names></name><name><surname>Jank</surname><given-names>M</given-names></name><name><surname>Sacharuk</surname><given-names>J</given-names></name><name><surname>Zieniewicz</surname><given-names>A</given-names></name><name><surname>Wilczak</surname><given-names>J</given-names></name><name><surname>Nissen</surname><given-names>S</given-names></name></person-group><article-title>Creatine and beta-hydroxy-beta-methylbutyrate (HMB) additively increase lean body mass and muscle strength during a weight-training program</article-title><source>Nutrition</source><year>2001</year><volume>17</volume><fpage>558</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1016/S0899-9007(01)00540-8</pub-id><pub-id pub-id-type="pmid">11448573</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kornasio</surname><given-names>R</given-names></name><name><surname>Riederer</surname><given-names>I</given-names></name><name><surname>Butler-Browne</surname><given-names>G</given-names></name><name><surname>Mouly</surname><given-names>V</given-names></name><name><surname>Uni</surname><given-names>Z</given-names></name><name><surname>Halevy</surname><given-names>O</given-names></name></person-group><article-title>Beta-hydroxy-beta-methylbutyrate (HMB) stimulates myogenic cell proliferation, differentiation and survival via the MAPK/ERK and PI3K/Akt pathway</article-title><source>Biochim Biophys Acta</source><year>2009</year><volume>1793</volume><fpage>755</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.1016/j.bbamcr.2008.12.017</pub-id><pub-id pub-id-type="pmid">19211028</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuang</surname><given-names>W</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Duan</surname><given-names>Y</given-names></name><name><surname>Duan</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Jin</surname><given-names>F</given-names></name><name><surname>Jin</surname><given-names>Z</given-names></name><name><surname>Yuan</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name></person-group><article-title>Cyclic stretch induced miR-146a upregulation delays C2C12 myogenic differentiation through inhibition of Numb</article-title><source>Biochem Biophys Res Commun</source><year>2009</year><volume>378</volume><fpage>259</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2008.11.041</pub-id><pub-id pub-id-type="pmid">19026611</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>JF</given-names></name><name><surname>Mandel</surname><given-names>EM</given-names></name><name><surname>Thomson</surname><given-names>JM</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Callis</surname><given-names>TE</given-names></name><name><surname>Hammond</surname><given-names>SM</given-names></name><name><surname>Conlon</surname><given-names>FL</given-names></name><name><surname>Wang</surname><given-names>DZ</given-names></name></person-group><article-title>The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation</article-title><source>Nat Genet</source><year>2006</year><volume>38</volume><fpage>228</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1038/ng1725</pub-id><pub-id pub-id-type="pmid">16380711</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardinali</surname><given-names>B</given-names></name><name><surname>Castellani</surname><given-names>L</given-names></name><name><surname>Fasanaro</surname><given-names>P</given-names></name><name><surname>Basso</surname><given-names>A</given-names></name><name><surname>Alem&#x000e0;</surname><given-names>S</given-names></name><name><surname>Martelli</surname><given-names>F</given-names></name><name><surname>Falcone</surname><given-names>G</given-names></name></person-group><article-title>Microrna-221 and microrna-222 modulate differentiation and maturation of skeletal muscle cells</article-title><source>PLoS One</source><year>2009</year><volume>4</volume><issue>10</issue><fpage>e7607</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0007607</pub-id><pub-id pub-id-type="pmid">19859555</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motohashi</surname><given-names>N</given-names></name><name><surname>Alexander</surname><given-names>MS</given-names></name><name><surname>Shimizu-Motohashi</surname><given-names>Y</given-names></name><name><surname>Myers</surname><given-names>JA</given-names></name><name><surname>Kawahara</surname><given-names>G</given-names></name><name><surname>Kunkel</surname><given-names>LM</given-names></name></person-group><article-title>Regulation of IRS1/Akt insulin signaling by microRNA-128a during myogenesis</article-title><source>J Cell Sci</source><year>2013</year><volume>126</volume><fpage>2678</fpage><lpage>2691</lpage><pub-id pub-id-type="doi">10.1242/jcs.119966</pub-id><pub-id pub-id-type="pmid">23606743</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dey</surname><given-names>BK</given-names></name><name><surname>Pfeifer</surname><given-names>K</given-names></name><name><surname>Dutta</surname><given-names>A</given-names></name></person-group><article-title>The H19 long noncoding RNA gives rise to microRNAs miR-675-3p and miR-675-5p to promote skeletal muscle differentiation and regeneration</article-title><source>Genes Dev</source><year>2014</year><volume>28</volume><issue>5</issue><fpage>491</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1101/gad.234419.113</pub-id><pub-id pub-id-type="pmid">24532688</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dmitriev</surname><given-names>P</given-names></name><name><surname>Barat</surname><given-names>A</given-names></name><name><surname>Polesskaya</surname><given-names>A</given-names></name><name><surname>O&#x02019;Connell</surname><given-names>MJ</given-names></name><name><surname>Robert</surname><given-names>T</given-names></name><name><surname>Dessen</surname><given-names>P</given-names></name><name><surname>Walsh</surname><given-names>TA</given-names></name><name><surname>Lazar</surname><given-names>V</given-names></name><name><surname>Turki</surname><given-names>A</given-names></name><name><surname>Carnac</surname><given-names>G</given-names></name><etal/></person-group><article-title>Simultaneous miRNA and mRNA transcriptome profiling of human myoblasts reveals a novel set of myogenic differentiation-associated miRNAs and their target genes</article-title><source>BMC Genomics</source><year>2013</year><volume>14</volume><fpage>265</fpage><pub-id pub-id-type="doi">10.1186/1471-2164-14-265</pub-id><pub-id pub-id-type="pmid">23597168</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>JF</given-names></name><name><surname>Tao</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>Z</given-names></name><name><surname>Yan</surname><given-names>Z</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>DZ</given-names></name></person-group><article-title>MicroRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7</article-title><source>J Cell Biol</source><year>2010</year><volume>190</volume><issue>5</issue><fpage>867</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1083/jcb.200911036</pub-id><pub-id pub-id-type="pmid">20819939</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Liang</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Pan</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Doevendans</surname><given-names>PA</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><etal/></person-group><article-title>MicroRNA-204 is required for differentiation of human-derived cardiomyocyte progenitor cells</article-title><source>J Mol Cell Cardiol</source><year>2012</year><volume>53</volume><fpage>751</fpage><lpage>759</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2012.08.024</pub-id><pub-id pub-id-type="pmid">22982025</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seok</surname><given-names>HY</given-names></name><name><surname>Tatsuguchi</surname><given-names>M</given-names></name><name><surname>Callis</surname><given-names>TE</given-names></name><name><surname>He</surname><given-names>A</given-names></name><name><surname>Pu</surname><given-names>WT</given-names></name><name><surname>Wang</surname><given-names>DZ</given-names></name></person-group><article-title>MiR-155 inhibits expression of the MEF2A protein to repress skeletal muscle differentiation</article-title><source>J Biol Chem</source><year>2011</year><volume>286</volume><fpage>35339</fpage><lpage>35346</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.273276</pub-id><pub-id pub-id-type="pmid">21868385</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Mori</surname><given-names>MA</given-names></name><name><surname>Alexander</surname><given-names>R</given-names></name><name><surname>Yuan</surname><given-names>B</given-names></name><name><surname>Hattangadi</surname><given-names>SM</given-names></name><name><surname>Lodish</surname><given-names>HF</given-names></name></person-group><article-title>Mir193b-365 is essential for brown fat differentiation</article-title><source>Nat Cell Biol</source><year>2011</year><volume>13</volume><fpage>958</fpage><lpage>965</lpage><pub-id pub-id-type="doi">10.1038/ncb2286</pub-id><pub-id pub-id-type="pmid">21743466</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araya</surname><given-names>R</given-names></name><name><surname>Eckardt</surname><given-names>D</given-names></name><name><surname>Maxeiner</surname><given-names>S</given-names></name><name><surname>Kr&#x000fc;ger</surname><given-names>O</given-names></name><name><surname>Theis</surname><given-names>M</given-names></name><name><surname>Willecke</surname><given-names>K</given-names></name><name><surname>S&#x000e1;ez</surname><given-names>JC</given-names></name></person-group><article-title>Expression of connexins during differentiation and regeneration of skeletal muscle: functional relevance of connexin43</article-title><source>J Cell Sci</source><year>2005</year><volume>118</volume><issue>1</issue><fpage>27</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1242/jcs.01553</pub-id><pub-id pub-id-type="pmid">15601660</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winbanks</surname><given-names>CE</given-names></name><name><surname>Beyer</surname><given-names>C</given-names></name><name><surname>Hagg</surname><given-names>A</given-names></name><name><surname>Qian</surname><given-names>H</given-names></name><name><surname>Sepulveda</surname><given-names>PV</given-names></name><name><surname>Gregorevic</surname><given-names>P</given-names></name></person-group><article-title>miR-206 represses hypertrophy of myogenic cells but not muscle fibers via inhibition of HDAC4</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e73589</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0073589</pub-id><pub-id pub-id-type="pmid">24023888</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhaumik</surname><given-names>DL</given-names></name><name><surname>Scott</surname><given-names>GK</given-names></name><name><surname>Schokrpur</surname><given-names>S</given-names></name><name><surname>Patil</surname><given-names>CK</given-names></name><name><surname>Orjalo</surname><given-names>AV</given-names></name><name><surname>Rodier</surname><given-names>F</given-names></name><name><surname>Lithgow</surname><given-names>GJ</given-names></name><name><surname>Campisi</surname><given-names>J</given-names></name></person-group><article-title>MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8</article-title><source>Aging</source><year>2009</year><volume>1</volume><fpage>402</fpage><pub-id pub-id-type="doi">10.18632/aging.100042</pub-id><pub-id pub-id-type="pmid">20148189</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taganov</surname><given-names>KD</given-names></name><name><surname>Boldin</surname><given-names>MP</given-names></name><name><surname>Chang</surname><given-names>KJ</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name></person-group><article-title>NF-&#x003ba;B-dependent induction of microRNA miR-146, an inhibitor targeted to signalling proteins of innate immune responses</article-title><source>Proc Natl Acad Sci</source><year>2006</year><volume>103</volume><fpage>12481</fpage><lpage>12486</lpage><pub-id pub-id-type="doi">10.1073/pnas.0605298103</pub-id><pub-id pub-id-type="pmid">16885212</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curtale</surname><given-names>G</given-names></name><name><surname>Mirolo</surname><given-names>M</given-names></name><name><surname>Renzi</surname><given-names>TA</given-names></name><name><surname>Rossato</surname><given-names>M</given-names></name><name><surname>Bazzoni</surname><given-names>F</given-names></name><name><surname>Locati</surname><given-names>M</given-names></name></person-group><article-title>Negative regulation of Toll-like receptor 4 signaling by IL-10-dependent microRNA-146b</article-title><source>Proc Natl Acad Sci U S A</source><year>2013</year><volume>110</volume><issue>28</issue><fpage>11499</fpage><lpage>11504</lpage><pub-id pub-id-type="doi">10.1073/pnas.1219852110</pub-id><pub-id pub-id-type="pmid">23798430</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Divangahi</surname><given-names>M</given-names></name><name><surname>Demoule</surname><given-names>A</given-names></name><name><surname>Danialou</surname><given-names>G</given-names></name><name><surname>Yahiaoui</surname><given-names>L</given-names></name><name><surname>Bao</surname><given-names>W</given-names></name><name><surname>Xing</surname><given-names>Z</given-names></name><name><surname>Petrof</surname><given-names>BJ</given-names></name></person-group><article-title>Impact of IL-10 on diaphragmatic cytokine expression and contractility during Pseudomonas infection</article-title><source>Am J Respir Cell Mol Biol</source><year>2007</year><volume>36</volume><issue>4</issue><fpage>504</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2006-0038OC</pub-id><pub-id pub-id-type="pmid">17122368</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ducharme</surname><given-names>NG</given-names></name><name><surname>Fortier</surname><given-names>LA</given-names></name><name><surname>Kraus</surname><given-names>MS</given-names></name><name><surname>Hobo</surname><given-names>S</given-names></name><name><surname>Mohammed</surname><given-names>HO</given-names></name><name><surname>McHugh</surname><given-names>MP</given-names></name><name><surname>Hackett</surname><given-names>RP</given-names></name><name><surname>Soderholm</surname><given-names>LV</given-names></name><name><surname>Mitchell</surname><given-names>LM</given-names></name></person-group><article-title>Effect of a tart cherry juice blend on exercise-induced muscle damage in horses</article-title><source>Am J Vet Res</source><year>2009</year><volume>70</volume><issue>6</issue><fpage>758</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.2460/ajvr.70.6.758</pub-id><pub-id pub-id-type="pmid">19496666</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Bassel-Duby</surname><given-names>R</given-names></name></person-group><article-title>Regulation of skeletal muscle development and disease by microRNAs</article-title><source>Results Probl Cell Differ</source><year>2015</year><volume>56</volume><fpage>165</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1007/978-3-662-44608-9_8</pub-id><pub-id pub-id-type="pmid">25344671</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehallo</surname><given-names>CJ</given-names></name><name><surname>Drezner</surname><given-names>JA</given-names></name><name><surname>Bytomski</surname><given-names>JR</given-names></name></person-group><article-title>Practical management: nonsteroidal antiinflammatory drug (NSAID) use in athletic injuries</article-title><source>Clin J Sport Med</source><year>2006</year><volume>16</volume><issue>2</issue><fpage>170</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1097/00042752-200603000-00015</pub-id><pub-id pub-id-type="pmid">16603889</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="other">Yakabe M, Ogawa S, Ota H, Iijima K, Eto M, Ouchi Y, Akishita M. Beta-hydroxy-beta-methylbutyrate inhibits lipopolysaccharide-induced Interleukin-6 expression by increasing protein phosphatase-1&#x003b1; expression. RNA Transcription. 2015:1&#x02013;5. 10.11648/j.rnat.20150101.11.</mixed-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steensberg</surname><given-names>A</given-names></name><name><surname>Febbraio</surname><given-names>MA</given-names></name><name><surname>Osada</surname><given-names>T</given-names></name><name><surname>Schjerling</surname><given-names>P</given-names></name><name><surname>Hall</surname><given-names>G</given-names></name><name><surname>Saltin</surname><given-names>B</given-names></name><name><surname>Pedersen</surname><given-names>BK</given-names></name></person-group><article-title>Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content</article-title><source>J Physiol</source><year>2001</year><volume>537</volume><issue>2</issue><fpage>633</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.1111/j.1469-7793.2001.00633.x</pub-id><pub-id pub-id-type="pmid">11731593</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sacheck</surname><given-names>JM</given-names></name><name><surname>Cannon</surname><given-names>JG</given-names></name><name><surname>Hamada</surname><given-names>K</given-names></name><name><surname>Vannier</surname><given-names>E</given-names></name><name><surname>Blumberg</surname><given-names>JB</given-names></name><name><surname>Roubenoff</surname><given-names>R</given-names></name></person-group><article-title>Age-related loss of associations between acute exercise-induced IL-6 and oxidative stress</article-title><source>Am J Physiol Endocrinol Metab</source><year>2006</year><volume>291</volume><issue>2</issue><fpage>E340</fpage><lpage>E349</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00052.2005</pub-id><pub-id pub-id-type="pmid">16507605</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nie</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Seok</surname><given-names>HY</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Deng</surname><given-names>ZL</given-names></name><name><surname>Wang</surname><given-names>DZ</given-names></name></person-group><article-title>MicroRNA-155 facilitates skeletal muscle regeneration by balancing pro-and anti-inflammatory macrophages</article-title><source>Cell Death Dis</source><year>2016</year><volume>7</volume><issue>6</issue><fpage>e2261</fpage><pub-id pub-id-type="doi">10.1038/cddis.2016.165</pub-id><pub-id pub-id-type="pmid">27277683</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>JM</given-names></name><name><surname>An</surname><given-names>J</given-names></name></person-group><article-title>Cytokines, inflammation and pain</article-title><source>Int Anesthesiol Clin</source><year>2007</year><volume>45</volume><issue>2</issue><fpage>27</fpage><pub-id pub-id-type="doi">10.1097/AIA.0b013e318034194e</pub-id><pub-id pub-id-type="pmid">17426506</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>TH</given-names></name><name><surname>Quach</surname><given-names>NL</given-names></name><name><surname>Charville</surname><given-names>GW</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Park</surname><given-names>L</given-names></name><name><surname>Edalati</surname><given-names>A</given-names></name><name><surname>Rando</surname><given-names>TA</given-names></name></person-group><article-title>Maintenance of muscle stem-cell quiescence by microRNA-489</article-title><source>Nature</source><year>2012</year><volume>482</volume><issue>7386</issue><fpage>524</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1038/nature10834</pub-id><pub-id pub-id-type="pmid">22358842</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khann</surname><given-names>N</given-names></name><name><surname>Ge</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>MicroRNA-146b promotes myogenic differentiation and modulates multiple gene targets in muscle cells</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>6</issue><fpage>e100657</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0100657</pub-id><pub-id pub-id-type="pmid">24956113</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>X</given-names></name><name><surname>Takahashi</surname><given-names>R</given-names></name><name><surname>Hiura</surname><given-names>Y</given-names></name><name><surname>Hirokawa</surname><given-names>G</given-names></name><name><surname>Fukushima</surname><given-names>Y</given-names></name><name><surname>Iwai</surname><given-names>N</given-names></name></person-group><article-title>Plasma miR-208 as a biomarker of myocardial injury</article-title><source>Clin Chem</source><year>2009</year><volume>55</volume><fpage>1944</fpage><lpage>1949</lpage><pub-id pub-id-type="doi">10.1373/clinchem.2009.125310</pub-id><pub-id pub-id-type="pmid">19696117</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Car&#x000e8;</surname><given-names>A</given-names></name><name><surname>Catalucci</surname><given-names>D</given-names></name><name><surname>Felicetti</surname><given-names>F</given-names></name><name><surname>Bonci</surname><given-names>D</given-names></name><name><surname>Addario</surname><given-names>A</given-names></name><name><surname>Gallo</surname><given-names>P</given-names></name><name><surname>Bang</surname><given-names>ML</given-names></name><name><surname>Segnalini</surname><given-names>P</given-names></name><name><surname>Gu</surname><given-names>Y</given-names></name><name><surname>Dalton</surname><given-names>ND</given-names></name><etal/></person-group><article-title>MicroRNA-133 controls cardiac hypertrophy</article-title><source>Nature med</source><year>2007</year><volume>13</volume><fpage>613</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.1038/nm1582</pub-id><pub-id pub-id-type="pmid">17468766</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Bishopric</surname><given-names>NH</given-names></name></person-group><article-title>Repression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophy</article-title><source>EMBO Mol Med</source><year>2012</year><volume>4</volume><issue>7</issue><fpage>617</fpage><lpage>632</lpage><pub-id pub-id-type="doi">10.1002/emmm.201200234</pub-id><pub-id pub-id-type="pmid">22367739</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>S</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name></person-group><article-title>MicroRNA-130b and microRNA-374b mediate the effect of maternal dietary protein on offspring lipid metabolism in Meishan pigs</article-title><source>Br J Nutr</source><year>2013</year><volume>109</volume><issue>10</issue><fpage>1731</fpage><lpage>1738</lpage><pub-id pub-id-type="doi">10.1017/S0007114512003728</pub-id><pub-id pub-id-type="pmid">22958366</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClung</surname><given-names>JM</given-names></name><name><surname>Judge</surname><given-names>AR</given-names></name><name><surname>Talbert</surname><given-names>EE</given-names></name><name><surname>Powers</surname><given-names>SK</given-names></name></person-group><article-title>Calpain-1 is required for hydrogen peroxide-induced myotube atrophy</article-title><source>Am J Physiol Cell Physiol</source><year>2009</year><volume>296</volume><issue>2</issue><fpage>C363</fpage><lpage>C371</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00497.2008</pub-id><pub-id pub-id-type="pmid">19109522</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohamed</surname><given-names>JS</given-names></name><name><surname>Hajira</surname><given-names>A</given-names></name><name><surname>Pardo</surname><given-names>PS</given-names></name><name><surname>Boriek</surname><given-names>AM</given-names></name></person-group><article-title>MicroRNA-149 inhibits PARP-2 and promotes mitochondrial biogenesis via SIRT-1/PGC-1&#x003b1; network in skeletal muscle</article-title><source>Diabetes</source><year>2014</year><volume>63</volume><issue>5</issue><fpage>1546</fpage><lpage>1559</lpage><pub-id pub-id-type="doi">10.2337/db13-1364</pub-id><pub-id pub-id-type="pmid">24757201</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JX</given-names></name><name><surname>Zhang</surname><given-names>XJ</given-names></name><name><surname>Feng</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group><article-title>MicroRNA-532-3p regulates mitochondrial fission through targeting apoptosis repressor with caspase recruitment domain in doxorubicin cardiotoxicity</article-title><source>Cell Death Dis</source><year>2015</year><volume>6</volume><issue>3</issue><fpage>e1677</fpage><pub-id pub-id-type="doi">10.1038/cddis.2015.41</pub-id><pub-id pub-id-type="pmid">25766316</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irani</surname><given-names>S</given-names></name><name><surname>Hussain</surname><given-names>MM</given-names></name></person-group><article-title>Role of microRNA-30c in lipid metabolism, adipogenesis, cardiac remodeling and cancer</article-title><source>Curr Opin Lipidol</source><year>2015</year><volume>26</volume><issue>2</issue><fpage>139</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1097/MOL.0000000000000162</pub-id><pub-id pub-id-type="pmid">25692340</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>MH</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Park</surname><given-names>WJ</given-names></name><name><surname>Yang</surname><given-names>DK</given-names></name></person-group><article-title>Identification of novel microRNAs negatively regulating cardiac hypertrophy</article-title><source>Biochem Biophys Res Commun</source><year>2012</year><volume>428</volume><issue>1</issue><fpage>191</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2012.10.040</pub-id><pub-id pub-id-type="pmid">23068096</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kureel</surname><given-names>J</given-names></name><name><surname>Dixit</surname><given-names>M</given-names></name><name><surname>Tyagi</surname><given-names>AM</given-names></name><name><surname>Mansoori</surname><given-names>MN</given-names></name><name><surname>Srivastava</surname><given-names>K</given-names></name><name><surname>Raghuvanshi</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>D</given-names></name></person-group><article-title>miR-542-3p suppresses osteoblast cell proliferation and differentiation, targets BMP-7 signaling and inhibits bone formation</article-title><source>Cell Death Dis</source><year>2014</year><volume>5</volume><issue>2</issue><fpage>e1050</fpage><pub-id pub-id-type="doi">10.1038/cddis.2014.4</pub-id><pub-id pub-id-type="pmid">24503542</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandur</surname><given-names>S</given-names></name><name><surname>Pankiv</surname><given-names>S</given-names></name><name><surname>Johannessen</surname><given-names>M</given-names></name><name><surname>Moens</surname><given-names>U</given-names></name><name><surname>Huseby</surname><given-names>NE</given-names></name></person-group><article-title>&#x003b3;-Glutamyltransferase is upregulated after oxidative stress through the Ras signal transduction pathway in rat colon carcinoma cells</article-title><source>Free Radic Res</source><year>2007</year><volume>41</volume><issue>12</issue><fpage>1376</fpage><lpage>1384</lpage><pub-id pub-id-type="doi">10.1080/10715760701739488</pub-id><pub-id pub-id-type="pmid">18075840</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tournadre</surname><given-names>A</given-names></name><name><surname>Lenief</surname><given-names>V</given-names></name><name><surname>Miossec</surname><given-names>P</given-names></name></person-group><article-title>Expression of toll-like receptor 3 and toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines</article-title><source>Arthritis Rheum</source><year>2010</year><volume>62</volume><issue>7</issue><fpage>2144</fpage><lpage>2151</lpage><pub-id pub-id-type="pmid">20309865</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>T</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name></person-group><article-title>Toll-like receptor and RIG-1-like receptor signaling</article-title><source>Ann N Y Acad Sci</source><year>2008</year><volume>1143</volume><issue>1</issue><fpage>1</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1196/annals.1443.020</pub-id><pub-id pub-id-type="pmid">19076341</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><mixed-citation publication-type="other">Szewczyk NJ, Peterson BK, Jacobson LA. Activation of Ras and the mitogen-activated protein kinase pathway promotes protein degradation in muscle cells of Caenorhabditis elegans. Mol Cell Biol. 2002;</mixed-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geisler</surname><given-names>HW</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Gerrard</surname><given-names>DE</given-names></name></person-group><article-title>MAPK pathway in skeletal muscle diseases</article-title><source>J Vet Sci Anim Husb</source><year>2013</year><volume>1</volume><issue>1</issue><fpage>e104</fpage></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gir&#x000f3;n</surname><given-names>MD</given-names></name><name><surname>V&#x000ed;lchez</surname><given-names>JD</given-names></name><name><surname>Shreeram</surname><given-names>S</given-names></name><name><surname>Salto</surname><given-names>R</given-names></name><name><surname>Manzano</surname><given-names>M</given-names></name><name><surname>Cabrera</surname><given-names>E</given-names></name><name><surname>L&#x000f3;pez-Pedrosa</surname><given-names>JM</given-names></name></person-group><article-title>&#x003b2;-Hydroxy-&#x003b2;-methylbutyrate (HMB) normalizes dexamethasone-induced autophagy-lysosomal pathway in skeletal muscle</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><issue>2</issue><fpage>e0117520</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0117520</pub-id><pub-id pub-id-type="pmid">25658432</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noh</surname><given-names>KK</given-names></name><name><surname>Chung</surname><given-names>KW</given-names></name><name><surname>Choi</surname><given-names>YJ</given-names></name><name><surname>Park</surname><given-names>MH</given-names></name><name><surname>Jang</surname><given-names>EJ</given-names></name><name><surname>Park</surname><given-names>CH</given-names></name><name><surname>Chung</surname><given-names>HY</given-names></name></person-group><article-title>&#x003b2;-Hydroxy &#x003b2;-methylbutyrate improves dexamethasone-induced muscle atrophy by modulating the muscle degradation pathway in SD rat</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>7</issue><fpage>e102947</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0102947</pub-id><pub-id pub-id-type="pmid">25032690</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>HJ</given-names></name><name><surname>Wyke</surname><given-names>SM</given-names></name><name><surname>Tisdale</surname><given-names>MJ</given-names></name></person-group><article-title>Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by &#x003b2;-hydroxy-&#x003b2;-methylbutyrate</article-title><source>Cancer Res</source><year>2004</year><volume>64</volume><issue>23</issue><fpage>8731</fpage><lpage>8735</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-1760</pub-id><pub-id pub-id-type="pmid">15574784</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallejo</surname><given-names>J</given-names></name><name><surname>Spence</surname><given-names>M</given-names></name><name><surname>Cheng</surname><given-names>AL</given-names></name><name><surname>Brotto</surname><given-names>L</given-names></name><name><surname>Edens</surname><given-names>NK</given-names></name><name><surname>Garvey</surname><given-names>SM</given-names></name><name><surname>Brotto</surname><given-names>M</given-names></name></person-group><article-title>Cellular and physiological effects of dietary supplementation with &#x003b2;-hydroxy-&#x003b2;-methylbutyrate (HMB) and &#x003b2;-alanine in late middle-aged mice</article-title><source>PLoS One</source><year>2016</year><volume>11</volume><issue>3</issue><fpage>e0150066</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0150066</pub-id><pub-id pub-id-type="pmid">26953693</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacini</surname><given-names>A</given-names></name><name><surname>Mannelli</surname><given-names>LDC</given-names></name><name><surname>Tenci</surname><given-names>B</given-names></name><name><surname>Maresca</surname><given-names>M</given-names></name><name><surname>Celi</surname><given-names>C</given-names></name><name><surname>Gabriele</surname><given-names>R</given-names></name><name><surname>Ghelardini</surname><given-names>C</given-names></name></person-group><article-title>Therapeutic option by synergistic administration of the &#x003b2;-hydroxy-&#x003b2;-methyl butyrate and R (+) lipoic acid in a cellular model of dexamethasone-dependent sarcopenia</article-title><source>Ital J Anat Embryol</source><year>2015</year><volume>120</volume><issue>1</issue><fpage>152</fpage></element-citation></ref></ref-list></back></article>